Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-17-5p ABCA1 3.27 0 -0.71 0.00276 MirTarget; TargetScan; miRNATAP -0.18 0 NA
2 hsa-miR-429 ABCA1 4.49 0 -0.71 0.00276 miRNATAP -0.11 0 NA
3 hsa-miR-192-5p ABCA8 2.69 0 -5.33 0 miRNAWalker2 validate -0.52 0 NA
4 hsa-miR-429 ABCA9 4.49 0 -3.14 0 miRanda -0.11 0.03127 NA
5 hsa-miR-429 ABCB1 4.49 0 -2.33 0 miRanda -0.11 0.00034 NA
6 hsa-miR-429 ABCB4 4.49 0 -1.92 0 miRanda -0.25 0 NA
7 hsa-miR-195-5p ABCB9 -1.45 0 1.34 0 mirMAP -0.11 0.00222 NA
8 hsa-miR-429 ABCC9 4.49 0 -2.76 0 miRanda; miRNATAP -0.39 0 NA
9 hsa-miR-17-5p ABCD2 3.27 0 -3.08 0 MirTarget -0.6 0 NA
10 hsa-miR-429 ABCD2 4.49 0 -3.08 0 miRanda -0.46 0 NA
11 hsa-miR-17-5p ABHD2 3.27 0 -0.37 0.12248 TargetScan; miRNATAP -0.11 0.00236 NA
12 hsa-miR-429 ABL2 4.49 0 -0.32 0.04554 MirTarget -0.13 0 NA
13 hsa-miR-429 ACAT1 4.49 0 -1.05 0 miRanda -0.19 0 NA
14 hsa-miR-429 ACE 4.49 0 -0.35 0.17613 miRanda -0.13 0 NA
15 hsa-miR-125b-5p ACER2 -1.16 0.00029 0.02 0.97526 MirTarget -0.37 1.0E-5 NA
16 hsa-miR-429 ACO1 4.49 0 -0.65 0.00055 miRanda -0.12 0 NA
17 hsa-miR-195-5p ACOT11 -1.45 0 0.06 0.86393 mirMAP -0.24 0.00021 NA
18 hsa-miR-17-5p ACOT2 3.27 0 -0.56 0.00263 miRNAWalker2 validate -0.13 0 NA
19 hsa-miR-429 ACOX2 4.49 0 -3.75 0 miRanda; miRNATAP -0.47 0 NA
20 hsa-miR-429 ACTC1 4.49 0 -7.19 0 MirTarget; miRanda; miRNATAP -0.99 0 NA
21 hsa-miR-429 ACTN1 4.49 0 -1.05 0.00011 miRanda -0.32 0 NA
22 hsa-miR-429 ACTN2 4.49 0 -3.37 0 miRanda -0.51 0 NA
23 hsa-miR-429 ACVR1 4.49 0 -0.44 0.01143 miRNATAP -0.13 0 NA
24 hsa-miR-125b-5p ACVR2A -1.16 0.00029 -0.44 0.02646 miRNATAP -0.14 0 NA
25 hsa-miR-17-5p ACVRL1 3.27 0 -1.25 0 TargetScan -0.26 0 NA
26 hsa-miR-429 ACVRL1 4.49 0 -1.25 0 miRNATAP -0.2 0 NA
27 hsa-miR-429 ADAM12 4.49 0 0.88 0.05623 miRanda; miRNATAP -0.3 0 NA
28 hsa-miR-17-5p ADAM19 3.27 0 -1.06 0.01895 mirMAP -0.35 0 NA
29 hsa-miR-429 ADAM19 4.49 0 -1.06 0.01895 miRanda; miRNATAP -0.44 0 NA
30 hsa-miR-429 ADAM23 4.49 0 -1.05 0.04992 miRanda -0.23 0 NA
31 hsa-miR-17-5p ADAM9 3.27 0 -0.2 0.40665 TargetScan; miRNATAP -0.16 1.0E-5 NA
32 hsa-miR-429 ADAMDEC1 4.49 0 0.24 0.71291 miRanda -0.36 0 NA
33 hsa-miR-429 ADAMTS1 4.49 0 -3.81 0 miRanda -0.24 0 NA
34 hsa-miR-429 ADAMTS10 4.49 0 -1.26 0.00027 miRNATAP -0.26 0 NA
35 hsa-miR-429 ADAMTS16 4.49 0 -1.54 0.01905 miRanda; miRNATAP -0.51 0 NA
36 hsa-miR-429 ADAMTS18 4.49 0 -0.74 0.14599 miRanda; miRNATAP -0.19 1.0E-5 NA
37 hsa-miR-429 ADAMTS2 4.49 0 -0.77 0.15763 miRNATAP -0.44 0 NA
38 hsa-miR-429 ADAMTS3 4.49 0 -1.18 0.00448 PITA; miRanda; miRNATAP -0.34 0 NA
39 hsa-miR-429 ADAMTS4 4.49 0 -2.17 0 miRanda -0.36 0 NA
40 hsa-miR-17-5p ADAMTS5 3.27 0 -2.16 0 TargetScan -0.37 0 NA
41 hsa-miR-429 ADAMTS6 4.49 0 -0.88 0.01914 miRNATAP -0.34 0 NA
42 hsa-miR-429 ADAMTS9 4.49 0 -1.79 0 PITA; miRanda -0.21 0 NA
43 hsa-miR-17-5p ADAMTSL2 3.27 0 -0.34 0.24934 TargetScan -0.11 0.01243 NA
44 hsa-miR-429 ADAP2 4.49 0 0.02 0.93649 miRanda -0.23 0 NA
45 hsa-miR-17-5p ADARB1 3.27 0 -1.93 0 miRNAWalker2 validate; MirTarget -0.35 0 NA
46 hsa-miR-192-5p ADARB1 2.69 0 -1.93 0 mirMAP -0.33 0 NA
47 hsa-miR-192-5p ADCY2 2.69 0 -3.87 0 mirMAP -0.58 0 NA
48 hsa-miR-429 ADCY2 4.49 0 -3.87 0 MirTarget; PITA; miRanda; miRNATAP -0.25 0 NA
49 hsa-miR-429 ADCY5 4.49 0 -5.17 0 miRNATAP -0.38 0 NA
50 hsa-miR-429 ADCY7 4.49 0 0.3 0.34571 miRanda -0.24 0 NA
51 hsa-miR-17-5p ADCY9 3.27 0 -1.5 0 mirMAP -0.31 0 NA
52 hsa-miR-429 ADCY9 4.49 0 -1.5 0 miRanda; miRNATAP -0.24 0 NA
53 hsa-miR-429 ADCYAP1 4.49 0 -3.51 0 miRanda -0.35 0 NA
54 hsa-miR-429 ADH1B 4.49 0 -7.89 0 miRanda -0.43 0 NA
55 hsa-miR-429 ADIPOQ 4.49 0 -5.02 0 miRanda -0.66 0 NA
56 hsa-miR-429 ADORA3 4.49 0 -0.39 0.2849 miRNATAP -0.31 0 NA
57 hsa-miR-17-5p ADRA1B 3.27 0 -0.45 0.38166 TargetScan -0.22 0.0039 NA
58 hsa-miR-429 ADRA2A 4.49 0 -2.58 0 miRNATAP -0.2 0 NA
59 hsa-miR-192-5p AFAP1 2.69 0 -0.98 0.00012 mirMAP -0.19 0 NA
60 hsa-miR-192-5p AFF2 2.69 0 -1.73 0.00201 mirMAP -0.21 0.01102 NA
61 hsa-miR-429 AFF2 4.49 0 -1.73 0.00201 miRNATAP -0.19 8.0E-5 NA
62 hsa-miR-429 AFF3 4.49 0 -5 0 MirTarget; PITA; miRanda; miRNATAP -0.43 0 NA
63 hsa-miR-17-5p AFF4 3.27 0 -0.82 0 TargetScan; miRNATAP -0.12 0 NA
64 hsa-miR-429 AGFG1 4.49 0 -0.17 0.30925 MirTarget; miRanda; miRNATAP -0.1 0 NA
65 hsa-miR-17-5p AGFG2 3.27 0 -0.51 0.00539 TargetScan; miRNATAP -0.14 0 NA
66 hsa-miR-125b-5p AGPAT3 -1.16 0.00029 0.21 0.13119 mirMAP -0.11 0 NA
67 hsa-miR-429 AGPAT4 4.49 0 -0.79 0.01174 miRNATAP -0.21 0 NA
68 hsa-miR-17-5p AHNAK 3.27 0 -1.66 0 TargetScan; miRNATAP -0.33 0 NA
69 hsa-miR-429 AHNAK 4.49 0 -1.66 0 PITA; miRanda; miRNATAP -0.19 0 NA
70 hsa-miR-17-5p AJAP1 3.27 0 -1.65 0.0004 TargetScan -0.18 0.01052 NA
71 hsa-miR-125b-5p AKAP1 -1.16 0.00029 -0.34 0.0302 miRNATAP -0.13 0 NA
72 hsa-miR-17-5p AKAP11 3.27 0 -0.8 0 MirTarget; TargetScan -0.15 0 NA
73 hsa-miR-17-5p AKAP13 3.27 0 -1.15 0 MirTarget; TargetScan; mirMAP; miRNATAP -0.26 0 NA
74 hsa-miR-429 AKAP13 4.49 0 -1.15 0 miRNATAP -0.13 0 NA
75 hsa-miR-429 AKAP2 4.49 0 -2.51 8.0E-5 PITA; miRanda; miRNATAP -0.51 0 NA
76 hsa-miR-429 AKAP5 4.49 0 0.05 0.84509 miRanda -0.13 0 NA
77 hsa-miR-429 AKAP6 4.49 0 -3.34 0 miRanda -0.39 0 NA
78 hsa-miR-17-5p AKT3 3.27 0 -1.94 0 TargetScan; miRNATAP -0.39 0 NA
79 hsa-miR-17-5p AKTIP 3.27 0 -0.35 0.01135 MirTarget; TargetScan; miRNATAP -0.13 0 NA
80 hsa-miR-429 ALDH1A1 4.49 0 -2.52 2.0E-5 miRanda -0.3 0 NA
81 hsa-miR-429 ALDH1L2 4.49 0 -1.12 0.02448 miRanda -0.49 0 NA
82 hsa-miR-429 ALDH7A1 4.49 0 -1.69 0.00179 miRanda -0.19 6.0E-5 NA
83 hsa-miR-17-5p ALPK3 3.27 0 -1.02 0.00049 mirMAP -0.3 0 NA
84 hsa-miR-429 ALX1 4.49 0 -0.87 0.17254 miRanda -0.23 5.0E-5 NA
85 hsa-miR-125b-5p AMIGO2 -1.16 0.00029 0.86 0.01664 MirTarget -0.22 5.0E-5 NA
86 hsa-miR-125b-5p AMIGO3 -1.16 0.00029 1.06 1.0E-5 mirMAP -0.14 0.00012 NA
87 hsa-miR-195-5p AMMECR1 -1.45 0 0.72 0.00063 miRNATAP -0.12 0.00362 NA
88 hsa-miR-192-5p AMOTL1 2.69 0 -1.62 0 mirMAP -0.3 0 NA
89 hsa-miR-429 AMOTL2 4.49 0 -1.01 0.00015 MirTarget; PITA; miRanda; miRNATAP -0.23 0 NA
90 hsa-miR-429 ANGPT1 4.49 0 -2 1.0E-5 miRanda -0.32 0 NA
91 hsa-miR-17-5p ANK2 3.27 0 -4.32 0 MirTarget; miRNATAP -0.75 0 NA
92 hsa-miR-429 ANK2 4.49 0 -4.32 0 miRanda; miRNATAP -0.54 0 NA
93 hsa-miR-17-5p ANKH 3.27 0 -0.38 0.21654 MirTarget; TargetScan -0.22 0 NA
94 hsa-miR-429 ANKH 4.49 0 -0.38 0.21654 PITA; miRanda; miRNATAP -0.26 0 NA
95 hsa-miR-17-5p ANKRD13A 3.27 0 -0.29 0.0581 mirMAP -0.11 0 NA
96 hsa-miR-195-5p ANKRD13D -1.45 0 0.69 4.0E-5 MirTarget -0.12 0.00016 NA
97 hsa-miR-17-5p ANKRD29 3.27 0 -3.47 0 MirTarget; TargetScan -0.71 0 NA
98 hsa-miR-125b-5p ANKRD50 -1.16 0.00029 -0.88 0.00174 miRNATAP -0.15 0.0004 NA
99 hsa-miR-17-5p ANKRD50 3.27 0 -0.88 0.00174 MirTarget; TargetScan; miRNATAP -0.18 2.0E-5 NA
100 hsa-miR-429 ANKS1B 4.49 0 -3.65 0 miRanda -0.39 0 NA
101 hsa-miR-429 ANO5 4.49 0 -3.19 0 miRanda -0.17 0.00049 NA
102 hsa-miR-17-5p ANO6 3.27 0 -0.74 3.0E-5 MirTarget; TargetScan; miRNATAP -0.14 0 NA
103 hsa-miR-429 ANTXR2 4.49 0 -2.31 0 miRNATAP -0.31 0 NA
104 hsa-miR-17-5p ANXA11 3.27 0 -0.43 0.01849 mirMAP -0.11 2.0E-5 NA
105 hsa-miR-192-5p AP1S2 2.69 0 -1.31 0 miRNAWalker2 validate -0.26 0 NA
106 hsa-miR-429 AP1S2 4.49 0 -1.31 0 MirTarget; PITA; miRanda; miRNATAP -0.29 0 NA
107 hsa-miR-429 AP4S1 4.49 0 -0.6 0.00055 miRanda; miRNATAP -0.11 0 NA
108 hsa-miR-429 APBB1 4.49 0 -2.48 0 miRNATAP -0.33 0 NA
109 hsa-miR-17-5p APBB2 3.27 0 -0.59 0.0014 MirTarget; TargetScan; miRNATAP -0.19 0 NA
110 hsa-miR-17-5p APCDD1 3.27 0 -1.6 0 MirTarget; TargetScan -0.2 0.00015 NA
111 hsa-miR-429 APCDD1L 4.49 0 -2.55 0.0003 miRNATAP -0.73 0 NA
112 hsa-miR-195-5p APLN -1.45 0 1.77 1.0E-5 MirTarget; miRNATAP -0.23 0.00329 NA
113 hsa-miR-429 APLN 4.49 0 1.77 1.0E-5 miRNATAP -0.13 0.0002 NA
114 hsa-miR-192-5p APOLD1 2.69 0 -2.62 0 miRNAWalker2 validate -0.22 0 NA
115 hsa-miR-17-5p APP 3.27 0 -0.4 0.04288 miRNAWalker2 validate; miRTarBase; TargetScan; miRNATAP -0.16 0 NA
116 hsa-miR-429 APP 4.49 0 -0.4 0.04288 miRanda -0.12 0 NA
117 hsa-miR-17-5p AR 3.27 0 -3.3 0 mirMAP -0.52 0 23095762 miR 17 5p targets the p300/CBP associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells; Targeting of the 3'-untranslated region of PCAF mRNA by miR-17-5p caused translational suppression and RNA degradation and consequently modulation of AR transcriptional activity in PCa cells; Targeting of PCAF by miR-17-5p modulates AR transcriptional activity and cell growth in cultured PCa cells
118 hsa-miR-429 AREG 4.49 0 -1.82 0.00455 miRanda -0.19 0.00063 NA
119 hsa-miR-17-5p ARHGAP1 3.27 0 -0.88 0 MirTarget; TargetScan; miRNATAP -0.23 0 NA
120 hsa-miR-429 ARHGAP1 4.49 0 -0.88 0 miRNATAP -0.12 0 NA
121 hsa-miR-17-5p ARHGAP10 3.27 0 -1.37 0 miRNAWalker2 validate -0.19 0 NA
122 hsa-miR-429 ARHGAP15 4.49 0 -1.33 0.00101 miRanda -0.28 0 NA
123 hsa-miR-429 ARHGAP20 4.49 0 -3.52 0 MirTarget; miRanda; miRNATAP -0.4 0 NA
124 hsa-miR-17-5p ARHGAP24 3.27 0 -2.02 0 MirTarget -0.46 0 NA
125 hsa-miR-429 ARHGAP24 4.49 0 -2.02 0 miRanda; miRNATAP -0.33 0 NA
126 hsa-miR-429 ARHGAP25 4.49 0 -0.72 0.00654 miRNATAP -0.21 0 NA
127 hsa-miR-17-5p ARHGAP26 3.27 0 -0.72 0.00357 MirTarget; TargetScan; mirMAP; miRNATAP -0.11 0.00432 NA
128 hsa-miR-429 ARHGAP28 4.49 0 -1.54 0.00053 MirTarget -0.11 0.00664 NA
129 hsa-miR-429 ARHGAP29 4.49 0 -0.34 0.31665 miRanda -0.15 0 NA
130 hsa-miR-17-5p ARHGAP31 3.27 0 -1.16 2.0E-5 TargetScan -0.32 0 NA
131 hsa-miR-195-5p ARHGAP32 -1.45 0 0.68 0.00492 MirTarget -0.16 0.00053 NA
132 hsa-miR-17-5p ARHGAP5 3.27 0 -0.63 0.00047 miRNAWalker2 validate -0.13 0 NA
133 hsa-miR-17-5p ARHGEF10 3.27 0 -1.15 1.0E-5 TargetScan -0.23 0 NA
134 hsa-miR-192-5p ARHGEF10 2.69 0 -1.15 1.0E-5 miRNAWalker2 validate -0.19 0 NA
135 hsa-miR-429 ARHGEF10 4.49 0 -1.15 1.0E-5 miRanda -0.2 0 NA
136 hsa-miR-429 ARHGEF17 4.49 0 -1.19 0 PITA; miRanda; miRNATAP -0.18 0 NA
137 hsa-miR-17-5p ARHGEF3 3.27 0 -0.76 0 MirTarget; TargetScan; miRNATAP -0.17 0 NA
138 hsa-miR-429 ARHGEF3 4.49 0 -0.76 0 MirTarget; PITA; miRanda; miRNATAP -0.11 0 NA
139 hsa-miR-192-5p ARHGEF37 2.69 0 -1.85 0 mirMAP -0.31 0 NA
140 hsa-miR-429 ARHGEF4 4.49 0 -1.44 0.0131 miRNATAP -0.27 0 NA
141 hsa-miR-429 ARHGEF6 4.49 0 -1.32 0 miRanda; mirMAP -0.13 0 NA
142 hsa-miR-125b-5p ARID3B -1.16 0.00029 0.53 0.00871 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.14 1.0E-5 22307404 miR 125b targets ARID3B in breast cancer cells; Among possible numerous targets of miR-125b we showed ARID3B AT-rich interactive domain 3B to be a novel target with roles in cell motility in breast cancer cells
143 hsa-miR-192-5p ARID5B 2.69 0 -1.57 0 mirMAP -0.22 0 NA
144 hsa-miR-429 ARID5B 4.49 0 -1.57 0 miRanda; miRNATAP -0.13 0 NA
145 hsa-miR-17-5p ARL10 3.27 0 -1.12 0.00198 mirMAP -0.19 0.00033 NA
146 hsa-miR-429 ARL10 4.49 0 -1.12 0.00198 mirMAP -0.18 0 NA
147 hsa-miR-192-5p ARL2BP 2.69 0 -0.34 0.00297 miRNAWalker2 validate; MirTarget -0.13 0 NA
148 hsa-miR-429 ARL4A 4.49 0 -0.62 0.01525 miRanda; miRNATAP -0.11 0 NA
149 hsa-miR-17-5p ARL4C 3.27 0 -0.28 0.33535 MirTarget; TargetScan; miRNATAP -0.19 1.0E-5 NA
150 hsa-miR-192-5p ARL4C 2.69 0 -0.28 0.33535 miRNAWalker2 validate -0.21 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 357 1672 3.721e-44 1.731e-40
2 REGULATION OF CELLULAR COMPONENT MOVEMENT 214 771 7.953e-44 1.85e-40
3 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 365 1848 2.868e-37 3.507e-34
4 REGULATION OF CELL DIFFERENTIATION 314 1492 3.015e-37 3.507e-34
5 BIOLOGICAL ADHESION 244 1032 4.144e-37 3.857e-34
6 TISSUE DEVELOPMENT 316 1518 1.597e-36 1.238e-33
7 CARDIOVASCULAR SYSTEM DEVELOPMENT 199 788 2.235e-34 1.3e-31
8 CIRCULATORY SYSTEM DEVELOPMENT 199 788 2.235e-34 1.3e-31
9 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 286 1395 1.022e-31 5.286e-29
10 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 230 1021 1.429e-31 6.65e-29
11 POSITIVE REGULATION OF RESPONSE TO STIMULUS 356 1929 4.569e-30 1.776e-27
12 VASCULATURE DEVELOPMENT 136 469 4.579e-30 1.776e-27
13 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 244 1142 9.085e-30 3.252e-27
14 CELL DEVELOPMENT 284 1426 2.876e-29 8.921e-27
15 REGULATION OF CELL PROLIFERATION 294 1496 2.689e-29 8.921e-27
16 LOCOMOTION 238 1114 5.043e-29 1.467e-26
17 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 314 1656 1.815e-28 4.968e-26
18 BLOOD VESSEL MORPHOGENESIS 113 364 5.883e-28 1.483e-25
19 NEUROGENESIS 277 1402 6.054e-28 1.483e-25
20 REGULATION OF PHOSPHORUS METABOLIC PROCESS 307 1618 7.34e-28 1.708e-25
21 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 258 1275 1.252e-27 2.774e-25
22 RESPONSE TO ENDOGENOUS STIMULUS 280 1450 1.365e-26 2.886e-24
23 POSITIVE REGULATION OF CELL COMMUNICATION 291 1532 1.915e-26 3.565e-24
24 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 220 1036 1.899e-26 3.565e-24
25 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 220 1036 1.899e-26 3.565e-24
26 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 212 1008 6.365e-25 1.139e-22
27 POSITIVE REGULATION OF LOCOMOTION 118 420 6.864e-25 1.168e-22
28 REGULATION OF CELL DEVELOPMENT 186 836 7.026e-25 1.168e-22
29 REGULATION OF PROTEIN MODIFICATION PROCESS 310 1710 1.133e-24 1.818e-22
30 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 178 799 6.712e-24 1.041e-21
31 REGULATION OF CELL ADHESION 151 629 9.079e-24 1.363e-21
32 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 277 1492 1.408e-23 2.047e-21
33 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 204 983 3.029e-23 4.27e-21
34 POSITIVE REGULATION OF CELL DIFFERENTIATION 180 823 3.321e-23 4.544e-21
35 NEGATIVE REGULATION OF CELL PROLIFERATION 151 643 9.499e-23 1.263e-20
36 RESPONSE TO OXYGEN CONTAINING COMPOUND 259 1381 1.132e-22 1.463e-20
37 CELL CELL ADHESION 145 608 1.459e-22 1.835e-20
38 POSITIVE REGULATION OF GENE EXPRESSION 306 1733 1.865e-22 2.284e-20
39 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 129 513 2.526e-22 3.014e-20
40 CELL MOTILITY 179 835 4.601e-22 5.221e-20
41 LOCALIZATION OF CELL 179 835 4.601e-22 5.221e-20
42 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 222 1135 8.633e-22 9.564e-20
43 EXTRACELLULAR STRUCTURE ORGANIZATION 91 304 1.627e-21 1.761e-19
44 NEGATIVE REGULATION OF CELL COMMUNICATION 229 1192 2.001e-21 2.116e-19
45 INTRACELLULAR SIGNAL TRANSDUCTION 281 1572 2.189e-21 2.264e-19
46 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 252 1360 2.569e-21 2.599e-19
47 ORGAN MORPHOGENESIS 177 841 6.402e-21 6.338e-19
48 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 171 801 6.564e-21 6.363e-19
49 ANGIOGENESIS 87 293 2.277e-20 2.162e-18
50 REGULATION OF NEURON DIFFERENTIATION 131 554 3.91e-20 3.639e-18
51 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 180 876 4.322e-20 3.943e-18
52 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 161 750 5.57e-20 4.984e-18
53 MUSCLE STRUCTURE DEVELOPMENT 110 432 1.222e-19 1.073e-17
54 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 190 957 1.899e-19 1.636e-17
55 POSITIVE REGULATION OF MOLECULAR FUNCTION 303 1791 2.43e-19 2.056e-17
56 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 304 1805 4.119e-19 3.422e-17
57 RESPONSE TO EXTERNAL STIMULUS 306 1821 4.324e-19 3.53e-17
58 RESPONSE TO ORGANIC CYCLIC COMPOUND 183 917 5.312e-19 4.261e-17
59 HEART DEVELOPMENT 114 466 7.363e-19 5.807e-17
60 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 300 1784 9.3e-19 7.212e-17
61 POSITIVE REGULATION OF CELL PROLIFERATION 167 814 1.263e-18 9.636e-17
62 EPITHELIUM DEVELOPMENT 184 945 6.138e-18 4.607e-16
63 BEHAVIOR 120 516 6.249e-18 4.615e-16
64 SKELETAL SYSTEM DEVELOPMENT 110 455 7.814e-18 5.681e-16
65 REGULATION OF MAPK CASCADE 140 660 4.931e-17 3.53e-15
66 POSITIVE REGULATION OF CATALYTIC ACTIVITY 259 1518 5.232e-17 3.689e-15
67 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 189 1004 8.005e-17 5.559e-15
68 REGULATION OF CELL DEATH 252 1472 9.694e-17 6.633e-15
69 POSITIVE REGULATION OF CELL DEVELOPMENT 110 472 1.327e-16 8.946e-15
70 CONNECTIVE TISSUE DEVELOPMENT 62 194 1.359e-16 9.035e-15
71 CELLULAR COMPONENT MORPHOGENESIS 173 900 2.346e-16 1.537e-14
72 NEURON DIFFERENTIATION 169 874 3.01e-16 1.945e-14
73 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 142 689 3.76e-16 2.397e-14
74 NEGATIVE REGULATION OF CELL DIFFERENTIATION 130 609 4.038e-16 2.539e-14
75 REGULATION OF CELL PROJECTION ORGANIZATION 122 558 5.136e-16 3.187e-14
76 REGULATION OF SYSTEM PROCESS 114 507 5.857e-16 3.586e-14
77 REGULATION OF TRANSPORT 292 1804 6.017e-16 3.636e-14
78 RESPONSE TO LIPID 170 888 6.46e-16 3.854e-14
79 CELLULAR RESPONSE TO LIPID 106 457 6.803e-16 4.007e-14
80 TAXIS 107 464 7.577e-16 4.407e-14
81 RESPONSE TO HORMONE 170 893 1.11e-15 6.378e-14
82 REGULATION OF NEURON PROJECTION DEVELOPMENT 97 408 2.255e-15 1.279e-13
83 RESPONSE TO WOUNDING 121 563 2.6e-15 1.457e-13
84 REGULATION OF EPITHELIAL CELL PROLIFERATION 76 285 4.051e-15 2.244e-13
85 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 117 541 4.765e-15 2.578e-13
86 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 117 541 4.765e-15 2.578e-13
87 SINGLE ORGANISM CELL ADHESION 104 459 6.733e-15 3.601e-13
88 SINGLE ORGANISM BEHAVIOR 92 384 7.283e-15 3.851e-13
89 TISSUE MORPHOGENESIS 115 533 9.774e-15 5.11e-13
90 RESPONSE TO GROWTH FACTOR 106 475 1.081e-14 5.586e-13
91 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 100 437 1.154e-14 5.901e-13
92 RESPONSE TO NITROGEN COMPOUND 162 859 1.288e-14 6.515e-13
93 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 104 465 1.661e-14 8.31e-13
94 POSITIVE REGULATION OF HYDROLASE ACTIVITY 168 905 1.745e-14 8.639e-13
95 MUSCLE TISSUE DEVELOPMENT 73 275 1.825e-14 8.939e-13
96 UROGENITAL SYSTEM DEVELOPMENT 77 299 2.05e-14 9.934e-13
97 TUBE DEVELOPMENT 117 552 2.141e-14 1.016e-12
98 REGULATION OF CELL MORPHOGENESIS 117 552 2.141e-14 1.016e-12
99 RESPONSE TO ABIOTIC STIMULUS 184 1024 2.226e-14 1.046e-12
100 POSITIVE REGULATION OF NEURON DIFFERENTIATION 78 306 2.516e-14 1.171e-12
101 POSITIVE REGULATION OF MAPK CASCADE 104 470 3.465e-14 1.596e-12
102 POSITIVE REGULATION OF CELL DEATH 124 605 4.606e-14 2.101e-12
103 CELLULAR RESPONSE TO NITROGEN COMPOUND 109 505 4.824e-14 2.179e-12
104 NEURON PROJECTION MORPHOGENESIS 93 402 4.988e-14 2.232e-12
105 NEGATIVE REGULATION OF PHOSPHORYLATION 96 422 5.802e-14 2.571e-12
106 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 87 368 8.947e-14 3.927e-12
107 CENTRAL NERVOUS SYSTEM DEVELOPMENT 161 872 1.025e-13 4.459e-12
108 REGULATION OF ION TRANSPORT 121 592 1.157e-13 4.986e-12
109 NEURON PROJECTION DEVELOPMENT 114 545 1.199e-13 5.117e-12
110 NEGATIVE REGULATION OF GENE EXPRESSION 243 1493 1.337e-13 5.656e-12
111 REGULATION OF VASCULATURE DEVELOPMENT 64 233 1.37e-13 5.743e-12
112 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 49 153 1.892e-13 7.862e-12
113 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 58 204 3.869e-13 1.593e-11
114 NEURON DEVELOPMENT 133 687 4.759e-13 1.943e-11
115 REGULATION OF OSSIFICATION 53 178 5.335e-13 2.159e-11
116 CELLULAR RESPONSE TO HORMONE STIMULUS 113 552 6.909e-13 2.771e-11
117 MESENCHYME DEVELOPMENT 55 190 7.006e-13 2.786e-11
118 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 80 337 7.106e-13 2.802e-11
119 REGULATION OF KINASE ACTIVITY 145 776 7.179e-13 2.807e-11
120 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 243 1517 7.753e-13 3.006e-11
121 CELL ACTIVATION 115 568 9.26e-13 3.561e-11
122 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 195 1152 1.25e-12 4.769e-11
123 CIRCULATORY SYSTEM PROCESS 84 366 1.333e-12 5.042e-11
124 WOUND HEALING 100 470 1.365e-12 5.122e-11
125 REGULATION OF EPITHELIAL CELL MIGRATION 50 166 1.49e-12 5.542e-11
126 PROTEIN PHOSPHORYLATION 167 944 1.501e-12 5.542e-11
127 IMMUNE SYSTEM PROCESS 300 1984 1.601e-12 5.867e-11
128 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 61 229 2.185e-12 7.944e-11
129 REGULATION OF GTPASE ACTIVITY 129 673 2.25e-12 8.114e-11
130 POSITIVE REGULATION OF CELL ADHESION 85 376 2.33e-12 8.34e-11
131 MUSCLE ORGAN DEVELOPMENT 69 277 2.525e-12 8.968e-11
132 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 37 103 3.515e-12 1.239e-10
133 RESPONSE TO CYTOKINE 134 714 4.029e-12 1.41e-10
134 REGULATION OF METAL ION TRANSPORT 76 325 5.913e-12 2.053e-10
135 REGULATION OF HYDROLASE ACTIVITY 215 1327 6.389e-12 2.186e-10
136 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 137 740 6.367e-12 2.186e-10
137 REGULATION OF BLOOD CIRCULATION 71 295 7.024e-12 2.385e-10
138 CARTILAGE DEVELOPMENT 45 147 1.044e-11 3.52e-10
139 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 295 1977 1.229e-11 4.113e-10
140 NEGATIVE REGULATION OF LOCOMOTION 65 263 1.572e-11 5.226e-10
141 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 42 133 1.651e-11 5.447e-10
142 REGULATION OF RESPONSE TO STRESS 231 1468 1.879e-11 6.157e-10
143 ACTIN FILAMENT BASED PROCESS 94 450 1.915e-11 6.231e-10
144 MORPHOGENESIS OF A BRANCHING STRUCTURE 48 167 2.655e-11 8.521e-10
145 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 71 303 2.653e-11 8.521e-10
146 REGULATION OF GROWTH 120 633 2.844e-11 9.063e-10
147 STEM CELL DIFFERENTIATION 52 190 3.045e-11 9.64e-10
148 POSITIVE REGULATION OF KINASE ACTIVITY 98 482 3.591e-11 1.129e-09
149 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 59 232 3.935e-11 1.229e-09
150 HEAD DEVELOPMENT 130 709 4.427e-11 1.373e-09
151 COGNITION 62 251 4.726e-11 1.456e-09
152 REGULATION OF CELLULAR LOCALIZATION 205 1277 4.874e-11 1.492e-09
153 RESPONSE TO MECHANICAL STIMULUS 55 210 5.333e-11 1.622e-09
154 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 45 154 5.995e-11 1.8e-09
155 AMEBOIDAL TYPE CELL MIGRATION 45 154 5.995e-11 1.8e-09
156 MORPHOGENESIS OF AN EPITHELIUM 85 400 7.133e-11 2.128e-09
157 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 66 278 7.252e-11 2.149e-09
158 REGULATION OF ORGAN MORPHOGENESIS 60 242 8.225e-11 2.422e-09
159 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 54 207 9.362e-11 2.74e-09
160 CELL PROJECTION ORGANIZATION 155 902 9.625e-11 2.799e-09
161 MUSCLE CELL DIFFERENTIATION 59 237 9.908e-11 2.864e-09
162 REGULATION OF CELL SUBSTRATE ADHESION 48 173 1.033e-10 2.967e-09
163 SENSORY ORGAN DEVELOPMENT 98 493 1.341e-10 3.827e-09
164 OSSIFICATION 61 251 1.378e-10 3.911e-09
165 MUSCLE SYSTEM PROCESS 66 282 1.396e-10 3.938e-09
166 REGULATION OF DEVELOPMENTAL GROWTH 67 289 1.569e-10 4.399e-09
167 REGULATION OF CARTILAGE DEVELOPMENT 26 63 1.612e-10 4.491e-09
168 NEURON PROJECTION GUIDANCE 53 205 1.995e-10 5.524e-09
169 TUBE MORPHOGENESIS 72 323 2.187e-10 6.021e-09
170 IMMUNE SYSTEM DEVELOPMENT 110 582 2.331e-10 6.381e-09
171 REGULATION OF OSTEOBLAST DIFFERENTIATION 36 112 2.611e-10 7.106e-09
172 CELL CELL SIGNALING 135 767 3.285e-10 8.887e-09
173 MESENCHYMAL CELL DIFFERENTIATION 40 134 3.38e-10 9.092e-09
174 EPITHELIAL CELL DIFFERENTIATION 97 495 3.746e-10 1.002e-08
175 REGULATION OF CELL CELL ADHESION 80 380 4.131e-10 1.098e-08
176 REGULATION OF CALCIUM ION TRANSPORT 53 209 4.276e-10 1.13e-08
177 KIDNEY EPITHELIUM DEVELOPMENT 38 125 5.188e-10 1.364e-08
178 CELL SUBSTRATE ADHESION 45 164 5.829e-10 1.524e-08
179 GROWTH 84 410 6.172e-10 1.604e-08
180 REGULATION OF CELLULAR COMPONENT BIOGENESIS 134 767 6.33e-10 1.636e-08
181 FOREBRAIN DEVELOPMENT 76 357 6.631e-10 1.705e-08
182 NEGATIVE REGULATION OF GROWTH 57 236 7.08e-10 1.81e-08
183 REGULATION OF ACTIN FILAMENT BASED PROCESS 69 312 7.422e-10 1.883e-08
184 HEART MORPHOGENESIS 53 212 7.447e-10 1.883e-08
185 REGULATION OF TRANSMEMBRANE TRANSPORT 86 426 8.287e-10 2.084e-08
186 REGULATION OF MUSCLE SYSTEM PROCESS 50 195 8.781e-10 2.197e-08
187 REGULATION OF RESPONSE TO WOUNDING 84 413 8.94e-10 2.213e-08
188 SKELETAL SYSTEM MORPHOGENESIS 51 201 8.893e-10 2.213e-08
189 LEUKOCYTE ACTIVATION 84 414 1.01e-09 2.487e-08
190 REGULATION OF IMMUNE SYSTEM PROCESS 215 1403 1.115e-09 2.731e-08
191 RESPONSE TO ALCOHOL 76 362 1.287e-09 3.119e-08
192 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 44 162 1.282e-09 3.119e-08
193 NEGATIVE REGULATION OF TRANSPORT 90 458 1.401e-09 3.377e-08
194 REGULATION OF MEMBRANE POTENTIAL 73 343 1.456e-09 3.492e-08
195 EMBRYONIC MORPHOGENESIS 101 539 2.072e-09 4.944e-08
196 NEPHRON DEVELOPMENT 35 115 2.39e-09 5.674e-08
197 CELLULAR RESPONSE TO CYTOKINE STIMULUS 110 606 2.585e-09 6.105e-08
198 REGULATION OF ERK1 AND ERK2 CASCADE 56 238 2.784e-09 6.541e-08
199 MESONEPHROS DEVELOPMENT 30 90 3.011e-09 7.041e-08
200 PHOSPHORYLATION 191 1228 3.209e-09 7.444e-08
201 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 48 190 3.216e-09 7.444e-08
202 STRIATED MUSCLE CELL DIFFERENTIATION 45 173 3.708e-09 8.542e-08
203 NEGATIVE REGULATION OF CELL DEATH 145 872 3.909e-09 8.96e-08
204 CARDIOCYTE DIFFERENTIATION 31 96 3.957e-09 9.025e-08
205 REGULATION OF HOMEOSTATIC PROCESS 87 447 4.262e-09 9.673e-08
206 LEUKOCYTE DIFFERENTIATION 64 292 4.426e-09 9.996e-08
207 REGULATION OF MAP KINASE ACTIVITY 68 319 4.932e-09 1.109e-07
208 CARDIAC MUSCLE TISSUE DEVELOPMENT 39 140 5.028e-09 1.125e-07
209 CELL PROLIFERATION 118 672 5.081e-09 1.126e-07
210 NEGATIVE REGULATION OF CELL ADHESION 53 223 5.068e-09 1.126e-07
211 REGULATION OF STEM CELL DIFFERENTIATION 34 113 5.589e-09 1.232e-07
212 RESPONSE TO PURINE CONTAINING COMPOUND 42 158 6.077e-09 1.334e-07
213 GLAND DEVELOPMENT 79 395 6.25e-09 1.365e-07
214 EMBRYO DEVELOPMENT 147 894 6.51e-09 1.415e-07
215 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 85 437 6.618e-09 1.426e-07
216 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 110 616 6.61e-09 1.426e-07
217 REGULATION OF PROTEIN LOCALIZATION 154 950 7.535e-09 1.616e-07
218 RESPONSE TO STEROID HORMONE 93 497 9.698e-09 2.07e-07
219 REGULATION OF TRANSFERASE ACTIVITY 153 946 9.885e-09 2.1e-07
220 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 93 498 1.074e-08 2.272e-07
221 REGULATION OF CELL ACTIVATION 91 484 1.102e-08 2.32e-07
222 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 89 470 1.124e-08 2.356e-07
223 TELENCEPHALON DEVELOPMENT 53 228 1.145e-08 2.389e-07
224 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 39 144 1.193e-08 2.478e-07
225 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 150 926 1.251e-08 2.587e-07
226 ENDOTHELIUM DEVELOPMENT 29 90 1.316e-08 2.71e-07
227 REGULATION OF ANATOMICAL STRUCTURE SIZE 89 472 1.386e-08 2.841e-07
228 REGULATION OF CHEMOTAXIS 45 180 1.395e-08 2.848e-07
229 POSITIVE REGULATION OF TRANSPORT 151 936 1.47e-08 2.987e-07
230 CELLULAR RESPONSE TO ACID CHEMICAL 44 175 1.675e-08 3.389e-07
231 ENDOTHELIAL CELL MIGRATION 22 57 1.805e-08 3.636e-07
232 AMINOGLYCAN BIOSYNTHETIC PROCESS 32 107 1.832e-08 3.674e-07
233 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 50 213 2.101e-08 4.179e-07
234 INOSITOL LIPID MEDIATED SIGNALING 35 124 2.099e-08 4.179e-07
235 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 24 67 2.29e-08 4.534e-07
236 CHEMICAL HOMEOSTASIS 142 874 2.572e-08 5.071e-07
237 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 141 867 2.712e-08 5.325e-07
238 REGULATION OF HEART CONTRACTION 51 221 2.772e-08 5.419e-07
239 LEARNING 36 131 2.848e-08 5.545e-07
240 CARDIAC MUSCLE CELL CONTRACTION 15 29 2.975e-08 5.769e-07
241 MULTICELLULAR ORGANISM METABOLIC PROCESS 29 93 3.008e-08 5.784e-07
242 DEVELOPMENTAL GROWTH 68 333 3.008e-08 5.784e-07
243 REGULATION OF CELL JUNCTION ASSEMBLY 24 68 3.194e-08 6.116e-07
244 REGULATION OF HOMOTYPIC CELL CELL ADHESION 64 307 3.384e-08 6.453e-07
245 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 66 321 3.634e-08 6.902e-07
246 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 20 50 3.926e-08 7.426e-07
247 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 41 162 4.176e-08 7.868e-07
248 TISSUE MIGRATION 27 84 4.384e-08 8.225e-07
249 CARDIAC MUSCLE CELL DIFFERENTIATION 25 74 4.525e-08 8.456e-07
250 RESPONSE TO ORGANOPHOSPHORUS 37 139 4.596e-08 8.554e-07
251 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 30 100 4.676e-08 8.669e-07
252 REGULATION OF SECRETION 118 699 4.957e-08 9.152e-07
253 CELL DEATH 157 1001 5.091e-08 9.363e-07
254 REGULATION OF CELL MATRIX ADHESION 28 90 5.477e-08 1.003e-06
255 RESPONSE TO OXYGEN LEVELS 64 311 5.63e-08 1.027e-06
256 MULTI MULTICELLULAR ORGANISM PROCESS 49 213 5.722e-08 1.036e-06
257 RESPONSE TO OXIDATIVE STRESS 70 352 5.72e-08 1.036e-06
258 ARTERY DEVELOPMENT 25 75 6.125e-08 1.105e-06
259 PALLIUM DEVELOPMENT 39 153 7.201e-08 1.294e-06
260 REGULATION OF INTRACELLULAR TRANSPORT 107 621 7.286e-08 1.304e-06
261 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 44 184 8.195e-08 1.461e-06
262 CELLULAR RESPONSE TO PEPTIDE 58 274 8.434e-08 1.498e-06
263 GLAND MORPHOGENESIS 29 97 8.472e-08 1.499e-06
264 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 106 616 8.975e-08 1.582e-06
265 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 10 14 9.261e-08 1.626e-06
266 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 35 131 9.517e-08 1.665e-06
267 REGULATION OF ENDOTHELIAL CELL MIGRATION 32 114 9.615e-08 1.676e-06
268 REGULATION OF MUSCLE TISSUE DEVELOPMENT 30 103 9.756e-08 1.694e-06
269 POSITIVE REGULATION OF ION TRANSPORT 52 236 1.014e-07 1.755e-06
270 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 29 98 1.085e-07 1.871e-06
271 REGULATION OF WOUND HEALING 34 126 1.112e-07 1.91e-06
272 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 36 138 1.21e-07 2.069e-06
273 CELL CHEMOTAXIS 40 162 1.252e-07 2.134e-06
274 CYTOKINE MEDIATED SIGNALING PATHWAY 83 452 1.405e-07 2.386e-06
275 GLIOGENESIS 42 175 1.437e-07 2.432e-06
276 REGULATION OF LEUKOCYTE DIFFERENTIATION 51 232 1.449e-07 2.443e-06
277 RENAL TUBULE DEVELOPMENT 25 78 1.462e-07 2.455e-06
278 CELLULAR RESPONSE TO BIOTIC STIMULUS 40 163 1.496e-07 2.503e-06
279 EYE DEVELOPMENT 65 326 1.525e-07 2.543e-06
280 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 19 49 1.544e-07 2.565e-06
281 REGULATION OF PROTEIN SECRETION 74 389 1.582e-07 2.62e-06
282 REGULATION OF ION HOMEOSTASIS 46 201 1.695e-07 2.797e-06
283 RESPONSE TO PEPTIDE 76 404 1.729e-07 2.843e-06
284 REGULATION OF MUSCLE CELL DIFFERENTIATION 38 152 1.816e-07 2.976e-06
285 SPROUTING ANGIOGENESIS 18 45 1.873e-07 3.058e-06
286 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 25 79 1.93e-07 3.14e-06
287 CELL PART MORPHOGENESIS 107 633 1.96e-07 3.175e-06
288 LYMPHOCYTE ACTIVATION 67 342 1.965e-07 3.175e-06
289 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 57 274 2.016e-07 3.246e-06
290 REGULATION OF MUSCLE CONTRACTION 37 147 2.181e-07 3.487e-06
291 LYMPHOCYTE DIFFERENTIATION 47 209 2.175e-07 3.487e-06
292 LEUKOCYTE CELL CELL ADHESION 54 255 2.295e-07 3.658e-06
293 GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS 13 25 2.337e-07 3.712e-06
294 HEART PROCESS 26 85 2.36e-07 3.736e-06
295 CARDIAC MUSCLE CELL ACTION POTENTIAL 16 37 2.488e-07 3.925e-06
296 RESPONSE TO REACTIVE OXYGEN SPECIES 44 191 2.56e-07 4.024e-06
297 REGULATION OF PEPTIDE TRANSPORT 54 256 2.621e-07 4.107e-06
298 CHONDROCYTE DIFFERENTIATION 21 60 2.7e-07 4.216e-06
299 REGULATION OF CHONDROCYTE DIFFERENTIATION 18 46 2.781e-07 4.327e-06
300 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 29 102 2.806e-07 4.352e-06
301 CELL MATRIX ADHESION 32 119 2.835e-07 4.383e-06
302 CELLULAR RESPONSE TO EXTERNAL STIMULUS 55 264 3.119e-07 4.794e-06
303 SKELETAL MUSCLE ORGAN DEVELOPMENT 35 137 3.122e-07 4.794e-06
304 REGULATION OF LEUKOCYTE MIGRATION 37 149 3.145e-07 4.813e-06
305 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 118 724 3.377e-07 5.152e-06
306 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 12 22 3.471e-07 5.278e-06
307 REGULATION OF MUSCLE ORGAN DEVELOPMENT 29 103 3.523e-07 5.339e-06
308 REGULATION OF AXONOGENESIS 40 168 3.534e-07 5.339e-06
309 BONE DEVELOPMENT 38 156 3.712e-07 5.589e-06
310 CARDIAC CHAMBER DEVELOPMENT 36 144 3.785e-07 5.681e-06
311 VASCULAR PROCESS IN CIRCULATORY SYSTEM 39 163 4.307e-07 6.443e-06
312 NEPHRON EPITHELIUM DEVELOPMENT 27 93 4.513e-07 6.731e-06
313 MODULATION OF SYNAPTIC TRANSMISSION 60 301 4.568e-07 6.791e-06
314 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 46 208 4.85e-07 7.188e-06
315 ENDOTHELIAL CELL DIFFERENTIATION 23 72 4.883e-07 7.212e-06
316 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 31 116 5.021e-07 7.394e-06
317 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 22 67 5.047e-07 7.408e-06
318 REGULATION OF CYTOPLASMIC TRANSPORT 85 481 5.45e-07 7.975e-06
319 REGULATION OF HORMONE SECRETION 54 262 5.69e-07 8.282e-06
320 RESPONSE TO BMP 27 94 5.713e-07 8.282e-06
321 CELLULAR RESPONSE TO BMP STIMULUS 27 94 5.713e-07 8.282e-06
322 NEGATIVE REGULATION OF NEURON DEATH 40 171 5.791e-07 8.368e-06
323 SYSTEM PROCESS 247 1785 5.981e-07 8.616e-06
324 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 19 53 6.493e-07 9.255e-06
325 MESONEPHRIC TUBULE MORPHOGENESIS 19 53 6.493e-07 9.255e-06
326 CELL JUNCTION ASSEMBLY 33 129 6.504e-07 9.255e-06
327 SKELETAL MUSCLE CELL DIFFERENTIATION 19 53 6.493e-07 9.255e-06
328 RESPONSE TO MONOAMINE 15 35 6.816e-07 9.669e-06
329 AMINOGLYCAN METABOLIC PROCESS 39 166 7.087e-07 1.002e-05
330 CELL JUNCTION ORGANIZATION 42 185 7.201e-07 1.015e-05
331 ACTIN MEDIATED CELL CONTRACTION 23 74 8.43e-07 1.185e-05
332 REGULATION OF HEMOPOIESIS 61 314 9.165e-07 1.285e-05
333 REGULATION OF LEUKOCYTE PROLIFERATION 45 206 9.237e-07 1.291e-05
334 MUSCLE CONTRACTION 49 233 1.012e-06 1.41e-05
335 REGULATION OF CYTOKINE PRODUCTION 95 563 1.024e-06 1.423e-05
336 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 15 36 1.057e-06 1.464e-05
337 REPRODUCTIVE SYSTEM DEVELOPMENT 74 408 1.073e-06 1.482e-05
338 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 23 75 1.098e-06 1.511e-05
339 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 14 32 1.187e-06 1.629e-05
340 RESPONSE TO DRUG 77 431 1.198e-06 1.639e-05
341 SECRETION 98 588 1.225e-06 1.672e-05
342 REGULATION OF KIDNEY DEVELOPMENT 19 55 1.249e-06 1.695e-05
343 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 13 28 1.248e-06 1.695e-05
344 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 58 296 1.262e-06 1.708e-05
345 NEGATIVE REGULATION OF CELL DEVELOPMENT 59 303 1.27e-06 1.713e-05
346 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 26 92 1.294e-06 1.741e-05
347 REGULATION OF BODY FLUID LEVELS 87 506 1.318e-06 1.768e-05
348 NEGATIVE REGULATION OF CELL GROWTH 39 170 1.342e-06 1.795e-05
349 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 31 121 1.356e-06 1.808e-05
350 REGULATION OF PROTEIN IMPORT 41 183 1.397e-06 1.857e-05
351 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 45 209 1.406e-06 1.858e-05
352 REGULATION OF PEPTIDE SECRETION 45 209 1.406e-06 1.858e-05
353 NEGATIVE REGULATION OF CELL ACTIVATION 37 158 1.47e-06 1.938e-05
354 CARDIAC CHAMBER MORPHOGENESIS 28 104 1.5e-06 1.966e-05
355 RESPONSE TO CAMP 28 104 1.5e-06 1.966e-05
356 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 36 152 1.526e-06 1.994e-05
357 REGULATION OF HORMONE LEVELS 83 478 1.535e-06 2.001e-05
358 REGULATION OF CELLULAR RESPONSE TO STRESS 111 691 1.542e-06 2.004e-05
359 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 15 37 1.608e-06 2.084e-05
360 ACTIN FILAMENT BASED MOVEMENT 26 93 1.621e-06 2.096e-05
361 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 43 197 1.634e-06 2.1e-05
362 RESPIRATORY SYSTEM DEVELOPMENT 43 197 1.634e-06 2.1e-05
363 HOMEOSTATIC PROCESS 191 1337 1.644e-06 2.107e-05
364 CARDIAC CONDUCTION 24 82 1.649e-06 2.108e-05
365 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 42 191 1.754e-06 2.236e-05
366 EMBRYONIC ORGAN DEVELOPMENT 73 406 1.765e-06 2.244e-05
367 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 39 172 1.828e-06 2.317e-05
368 SIALYLATION 11 21 1.853e-06 2.343e-05
369 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 46 218 1.944e-06 2.451e-05
370 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 33 135 1.953e-06 2.456e-05
371 MULTICELLULAR ORGANISMAL SIGNALING 31 123 1.978e-06 2.481e-05
372 SECOND MESSENGER MEDIATED SIGNALING 37 160 2.026e-06 2.535e-05
373 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 13 29 2.048e-06 2.555e-05
374 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 28 106 2.263e-06 2.816e-05
375 COLLAGEN FIBRIL ORGANIZATION 15 38 2.403e-06 2.982e-05
376 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 24 84 2.647e-06 3.267e-05
377 POSITIVE REGULATION OF OSSIFICATION 24 84 2.647e-06 3.267e-05
378 GANGLIOSIDE BIOSYNTHETIC PROCESS 10 18 2.738e-06 3.37e-05
379 ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 21 68 2.81e-06 3.44e-05
380 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 21 68 2.81e-06 3.44e-05
381 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 72 404 2.883e-06 3.521e-05
382 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 52 262 2.971e-06 3.619e-05
383 RESPONSE TO INORGANIC SUBSTANCE 82 479 3.139e-06 3.813e-05
384 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 159 1087 3.327e-06 4.031e-05
385 RESPONSE TO ACID CHEMICAL 60 319 3.343e-06 4.032e-05
386 REGULATION OF CELL GROWTH 70 391 3.345e-06 4.032e-05
387 POSITIVE REGULATION OF CHEMOTAXIS 30 120 3.44e-06 4.135e-05
388 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 72 406 3.459e-06 4.149e-05
389 EMBRYO IMPLANTATION 15 39 3.533e-06 4.225e-05
390 POSITIVE REGULATION OF CELL CELL ADHESION 49 243 3.571e-06 4.26e-05
391 ION TRANSPORT 180 1262 3.684e-06 4.384e-05
392 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 9 15 3.72e-06 4.415e-05
393 NEGATIVE REGULATION OF MAPK CASCADE 34 145 3.737e-06 4.424e-05
394 REGULATION OF NEUROTRANSMITTER TRANSPORT 20 64 3.933e-06 4.645e-05
395 NEURAL CREST CELL DIFFERENTIATION 22 75 4.248e-06 5.004e-05
396 CELL ADHESION MEDIATED BY INTEGRIN 8 12 4.354e-06 5.116e-05
397 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 67 372 4.365e-06 5.116e-05
398 REGULATION OF NEURON DEATH 50 252 4.609e-06 5.389e-05
399 LEUKOCYTE MIGRATION 51 259 4.665e-06 5.44e-05
400 WNT SIGNALING PATHWAY 64 351 4.684e-06 5.448e-05
401 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 47 232 4.905e-06 5.692e-05
402 FORMATION OF PRIMARY GERM LAYER 28 110 4.953e-06 5.733e-05
403 REGULATION OF NEURON APOPTOTIC PROCESS 41 192 5.035e-06 5.813e-05
404 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 19 60 5.485e-06 6.317e-05
405 SECRETION BY CELL 82 486 5.558e-06 6.37e-05
406 RESPONSE TO EXTRACELLULAR STIMULUS 76 441 5.557e-06 6.37e-05
407 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 12 27 5.688e-06 6.503e-05
408 REGULATION OF ADHERENS JUNCTION ORGANIZATION 17 50 5.77e-06 6.565e-05
409 LIPID PHOSPHORYLATION 26 99 5.771e-06 6.565e-05
410 T CELL DIFFERENTIATION 30 123 5.891e-06 6.686e-05
411 CEREBRAL CORTEX DEVELOPMENT 27 105 5.916e-06 6.698e-05
412 KIDNEY MORPHOGENESIS 23 82 5.986e-06 6.761e-05
413 NEGATIVE REGULATION OF SECRETION 42 200 6.049e-06 6.815e-05
414 CELL FATE COMMITMENT 46 227 6.11e-06 6.867e-05
415 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 97 602 6.133e-06 6.876e-05
416 HEMOSTASIS 58 311 6.341e-06 7.092e-05
417 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 32 136 6.596e-06 7.343e-05
418 GLIAL CELL DIFFERENTIATION 32 136 6.596e-06 7.343e-05
419 REGULATION OF VASOCONSTRICTION 20 66 6.654e-06 7.389e-05
420 LOCOMOTORY BEHAVIOR 39 181 6.768e-06 7.498e-05
421 REGULATION OF BMP SIGNALING PATHWAY 22 77 6.828e-06 7.546e-05
422 FAT CELL DIFFERENTIATION 27 106 7.165e-06 7.9e-05
423 MEMBRANE DEPOLARIZATION 19 61 7.199e-06 7.919e-05
424 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 15 41 7.295e-06 7.987e-05
425 POSITIVE REGULATION OF RESPONSE TO WOUNDING 36 162 7.281e-06 7.987e-05
426 CELLULAR RESPONSE TO OXYGEN LEVELS 33 143 7.422e-06 8.107e-05
427 PROTEOGLYCAN METABOLIC PROCESS 23 83 7.478e-06 8.149e-05
428 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 35 156 7.757e-06 8.433e-05
429 ADIPOSE TISSUE DEVELOPMENT 13 32 7.781e-06 8.44e-05
430 ARTERY MORPHOGENESIS 17 51 7.826e-06 8.468e-05
431 NEGATIVE REGULATION OF KINASE ACTIVITY 49 250 8.113e-06 8.759e-05
432 EMBRYONIC ORGAN MORPHOGENESIS 53 279 9.087e-06 9.765e-05
433 ACTIVATION OF PROTEIN KINASE ACTIVITY 53 279 9.087e-06 9.765e-05
434 REGULATION OF MONOCYTE CHEMOTAXIS 10 20 9.512e-06 0.000102
435 REGULATION OF ORGAN GROWTH 21 73 9.767e-06 0.0001045
436 CELLULAR CHEMICAL HOMEOSTASIS 92 570 9.87e-06 0.0001053
437 CYCLIC NUCLEOTIDE METABOLIC PROCESS 18 57 1.006e-05 0.0001071
438 SYNAPSE ORGANIZATION 33 145 1.014e-05 0.0001078
439 REGULATION OF CYTOPLASMIC TRANSLATION 8 13 1.029e-05 0.0001091
440 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 27 108 1.041e-05 0.0001098
441 MUCOPOLYSACCHARIDE METABOLIC PROCESS 27 108 1.041e-05 0.0001098
442 ORGAN GROWTH 20 68 1.097e-05 0.0001155
443 REGULATION OF TRANSPORTER ACTIVITY 41 198 1.111e-05 0.0001166
444 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 46 233 1.247e-05 0.0001306
445 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 27 109 1.249e-05 0.0001306
446 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 34 153 1.291e-05 0.0001347
447 POSITIVE REGULATION OF CELL ACTIVATION 57 311 1.298e-05 0.0001351
448 PEPTIDYL TYROSINE MODIFICATION 39 186 1.328e-05 0.0001379
449 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 14 38 1.338e-05 0.0001387
450 MUSCLE CELL DEVELOPMENT 30 128 1.373e-05 0.0001419
451 NEGATIVE REGULATION OF OSSIFICATION 20 69 1.396e-05 0.000144
452 NEURON MIGRATION 27 110 1.494e-05 0.0001538
453 MEMORY 25 98 1.501e-05 0.0001541
454 ION HOMEOSTASIS 92 576 1.506e-05 0.0001541
455 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 26 104 1.507e-05 0.0001541
456 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 31 135 1.539e-05 0.000157
457 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 21 75 1.546e-05 0.0001574
458 METANEPHROS DEVELOPMENT 22 81 1.661e-05 0.0001688
459 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 34 1.705e-05 0.0001721
460 RESPONSE TO FLUID SHEAR STRESS 13 34 1.705e-05 0.0001721
461 CAMP METABOLIC PROCESS 13 34 1.705e-05 0.0001721
462 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 64 365 1.71e-05 0.0001722
463 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 46 236 1.756e-05 0.0001765
464 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 20 70 1.766e-05 0.0001771
465 POSITIVE REGULATION OF BLOOD CIRCULATION 24 93 1.792e-05 0.0001793
466 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 14 39 1.89e-05 0.0001883
467 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 14 39 1.89e-05 0.0001883
468 REGULATION OF CALCIUM MEDIATED SIGNALING 21 76 1.93e-05 0.0001919
469 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 15 44 1.959e-05 0.0001943
470 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 32 143 1.975e-05 0.0001955
471 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 65 1.993e-05 0.0001969
472 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 12 30 2.105e-05 0.0002075
473 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 8 14 2.182e-05 0.0002138
474 ACTION POTENTIAL 24 94 2.173e-05 0.0002138
475 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 8 14 2.182e-05 0.0002138
476 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 18 60 2.216e-05 0.0002166
477 NEGATIVE REGULATION OF CELL CELL ADHESION 31 138 2.441e-05 0.0002381
478 SENSORY ORGAN MORPHOGENESIS 46 239 2.45e-05 0.0002385
479 REGULATION OF TYPE 2 IMMUNE RESPONSE 11 26 2.485e-05 0.0002409
480 GANGLIOSIDE METABOLIC PROCESS 11 26 2.485e-05 0.0002409
481 REGULATION OF CARDIAC MUSCLE CONTRACTION 19 66 2.53e-05 0.0002447
482 EPITHELIAL CELL PROLIFERATION 23 89 2.596e-05 0.0002506
483 REGULATION OF EXTENT OF CELL GROWTH 25 101 2.619e-05 0.0002523
484 ENDOCHONDRAL BONE MORPHOGENESIS 15 45 2.659e-05 0.0002556
485 OSTEOBLAST DIFFERENTIATION 29 126 2.729e-05 0.0002613
486 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 29 126 2.729e-05 0.0002613
487 CELLULAR RESPONSE TO INTERLEUKIN 6 10 22 2.74e-05 0.0002618
488 RHYTHMIC PROCESS 54 298 3.003e-05 0.0002863
489 RESPONSE TO TOXIC SUBSTANCE 46 241 3.045e-05 0.0002898
490 REGULATION OF PLATELET ACTIVATION 12 31 3.112e-05 0.0002949
491 REGULATION OF SYNAPTIC VESICLE TRANSPORT 12 31 3.112e-05 0.0002949
492 EPITHELIAL CELL DEVELOPMENT 38 186 3.135e-05 0.0002965
493 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 39 193 3.218e-05 0.0003037
494 REGULATION OF NEUROTRANSMITTER SECRETION 16 51 3.395e-05 0.0003198
495 POSITIVE REGULATION OF STAT CASCADE 20 73 3.46e-05 0.0003246
496 POSITIVE REGULATION OF JAK STAT CASCADE 20 73 3.46e-05 0.0003246
497 CELLULAR HOMEOSTASIS 103 676 3.573e-05 0.0003345
498 CELL SUBSTRATE JUNCTION ASSEMBLY 14 41 3.618e-05 0.000338
499 BONE MORPHOGENESIS 21 79 3.648e-05 0.0003402
500 CARDIAC SEPTUM DEVELOPMENT 22 85 3.761e-05 0.00035
501 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 28 122 3.934e-05 0.0003654
502 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 38 188 4.012e-05 0.0003704
503 NERVE DEVELOPMENT 19 68 4.004e-05 0.0003704
504 CELLULAR LIPID METABOLIC PROCESS 132 913 4e-05 0.0003704
505 EAR DEVELOPMENT 39 195 4.095e-05 0.0003766
506 REGULATION OF INFLAMMATORY RESPONSE 53 294 4.092e-05 0.0003766
507 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 42 216 4.231e-05 0.0003883
508 PLATELET ACTIVATION 31 142 4.388e-05 0.0004014
509 REGULATION OF OSTEOBLAST PROLIFERATION 10 23 4.399e-05 0.0004014
510 INNERVATION 10 23 4.399e-05 0.0004014
511 ACTIVATION OF MAPKK ACTIVITY 16 52 4.437e-05 0.000404
512 ENDOCARDIAL CUSHION DEVELOPMENT 12 32 4.513e-05 0.0004101
513 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 34 162 4.526e-05 0.0004106
514 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 22 86 4.566e-05 0.0004133
515 REGULATION OF MUSCLE ADAPTATION 18 63 4.584e-05 0.0004142
516 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 9 19 4.667e-05 0.0004209
517 LIPID MODIFICATION 41 210 4.71e-05 0.0004233
518 REGULATION OF BLOOD PRESSURE 35 169 4.713e-05 0.0004233
519 POSITIVE REGULATION OF DEPHOSPHORYLATION 15 47 4.747e-05 0.0004255
520 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 87 554 4.786e-05 0.0004283
521 REGULATION OF RECEPTOR ACTIVITY 27 117 4.845e-05 0.0004327
522 LIPID METABOLIC PROCESS 161 1158 4.864e-05 0.0004327
523 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 13 37 4.862e-05 0.0004327
524 REGULATION OF HEART GROWTH 14 42 4.913e-05 0.0004363
525 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 33 156 4.934e-05 0.0004369
526 POSITIVE REGULATION OF CYTOKINE PRODUCTION 63 370 4.939e-05 0.0004369
527 REGULATION OF MYELOID CELL DIFFERENTIATION 37 183 5.002e-05 0.00044
528 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 19 69 4.995e-05 0.00044
529 POSITIVE REGULATION OF AXONOGENESIS 19 69 4.995e-05 0.00044
530 INFLAMMATORY RESPONSE 74 454 5.119e-05 0.0004494
531 PROTEOGLYCAN BIOSYNTHETIC PROCESS 17 58 5.178e-05 0.0004537
532 SENSORY PERCEPTION OF PAIN 20 75 5.282e-05 0.000462
533 GLUCOSE HOMEOSTASIS 35 170 5.354e-05 0.0004665
534 CARBOHYDRATE HOMEOSTASIS 35 170 5.354e-05 0.0004665
535 STRIATED MUSCLE CONTRACTION 24 99 5.411e-05 0.000468
536 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 24 99 5.411e-05 0.000468
537 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 24 99 5.411e-05 0.000468
538 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 24 99 5.411e-05 0.000468
539 REGULATION OF SPROUTING ANGIOGENESIS 11 28 5.679e-05 0.0004902
540 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 16 53 5.751e-05 0.0004955
541 MUSCLE ORGAN MORPHOGENESIS 19 70 6.199e-05 0.0005321
542 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 19 70 6.199e-05 0.0005321
543 REGULATION OF FAT CELL DIFFERENTIATION 25 106 6.219e-05 0.0005329
544 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 48 6.249e-05 0.0005335
545 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 15 48 6.249e-05 0.0005335
546 DIVALENT INORGANIC CATION HOMEOSTASIS 59 343 6.296e-05 0.0005365
547 RESPONSE TO VITAMIN D 12 33 6.427e-05 0.000546
548 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 24 100 6.431e-05 0.000546
549 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 42 220 6.571e-05 0.0005566
550 VASCULOGENESIS 17 59 6.579e-05 0.0005566
551 CERAMIDE BIOSYNTHETIC PROCESS 14 43 6.597e-05 0.0005571
552 INTEGRIN MEDIATED SIGNALING PATHWAY 21 82 6.624e-05 0.0005584
553 REGULATION OF STEM CELL PROLIFERATION 22 88 6.651e-05 0.0005597
554 REGULATION OF CELL SIZE 35 172 6.879e-05 0.0005777
555 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 60 352 7.152e-05 0.0005996
556 DEVELOPMENTAL MATURATION 38 193 7.262e-05 0.0006077
557 REGULATION OF SEQUESTERING OF CALCIUM ION 25 107 7.329e-05 0.000609
558 REGULATION OF T CELL DIFFERENTIATION 25 107 7.329e-05 0.000609
559 REGULATION OF JNK CASCADE 33 159 7.321e-05 0.000609
560 PLATELET DEGRANULATION 25 107 7.329e-05 0.000609
561 IMMUNE RESPONSE 153 1100 7.344e-05 0.0006091
562 AGING 48 264 7.423e-05 0.0006146
563 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 9 20 7.707e-05 0.0006367
564 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 8 16 7.731e-05 0.0006367
565 RESPONSE TO EPINEPHRINE 8 16 7.731e-05 0.0006367
566 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 23 95 7.844e-05 0.0006426
567 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 23 95 7.844e-05 0.0006426
568 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 23 95 7.844e-05 0.0006426
569 SPHINGOLIPID BIOSYNTHETIC PROCESS 20 77 7.912e-05 0.000647
570 RESPONSE TO HEAT 22 89 7.983e-05 0.0006505
571 POST EMBRYONIC DEVELOPMENT 22 89 7.983e-05 0.0006505
572 GLOMERULUS DEVELOPMENT 15 49 8.151e-05 0.0006619
573 CARDIAC SEPTUM MORPHOGENESIS 15 49 8.151e-05 0.0006619
574 REGULATION OF SMOOTH MUSCLE CONTRACTION 17 60 8.304e-05 0.0006732
575 REGULATION OF CATABOLIC PROCESS 108 731 8.407e-05 0.0006803
576 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 14 44 8.761e-05 0.0007077
577 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 34 9.002e-05 0.0007173
578 REGULATION OF WNT SIGNALING PATHWAY 54 310 8.991e-05 0.0007173
579 REGULATION OF MESENCHYMAL CELL PROLIFERATION 12 34 9.002e-05 0.0007173
580 SEX DIFFERENTIATION 48 266 8.991e-05 0.0007173
581 HEART VALVE DEVELOPMENT 12 34 9.002e-05 0.0007173
582 EXOCYTOSIS 54 310 8.991e-05 0.0007173
583 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 24 102 8.999e-05 0.0007173
584 RENAL SYSTEM PROCESS 24 102 8.999e-05 0.0007173
585 REGULATION OF LEUKOCYTE CHEMOTAXIS 23 96 9.319e-05 0.0007412
586 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 26 115 9.544e-05 0.0007553
587 CELLULAR RESPONSE TO ALCOHOL 26 115 9.544e-05 0.0007553
588 RESPONSE TO CALCIUM ION 26 115 9.544e-05 0.0007553
589 LYMPHOCYTE COSTIMULATION 20 78 9.618e-05 0.0007598
590 RESPONSE TO KETONE 36 182 0.0001006 0.0007933
591 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 25 109 0.0001009 0.0007947
592 CELL GROWTH 29 135 0.0001033 0.000812
593 MEMBRANE ASSEMBLY 10 25 0.0001035 0.0008123
594 GASTRULATION 32 155 0.0001038 0.000813
595 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 27 122 0.000104 0.0008133
596 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 15 50 0.0001054 0.0008216
597 CELLULAR RESPONSE TO CAMP 15 50 0.0001054 0.0008216
598 REGULATION OF CALCIUM ION IMPORT 24 103 0.000106 0.0008247
599 PATTERN SPECIFICATION PROCESS 68 418 0.0001075 0.000835
600 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 23 97 0.0001104 0.0008558
601 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 41 218 0.0001125 0.0008712
602 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 40 211 0.0001135 0.0008755
603 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 40 211 0.0001135 0.0008755
604 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 21 85 0.0001159 0.000893
605 DENDRITE DEVELOPMENT 20 79 0.0001164 0.0008953
606 MEMBRANE BIOGENESIS 11 30 0.0001188 0.0009124
607 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 13 0.0001221 0.0009331
608 NEGATIVE REGULATION OF ORGAN GROWTH 9 21 0.0001225 0.0009331
609 REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS 9 21 0.0001225 0.0009331
610 LYMPH VESSEL MORPHOGENESIS 7 13 0.0001221 0.0009331
611 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 40 0.0001221 0.0009331
612 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 76 482 0.0001231 0.0009362
613 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 26 117 0.000129 0.0009791
614 FOREBRAIN CELL MIGRATION 17 62 0.0001298 0.0009821
615 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 17 62 0.0001298 0.0009821
616 REGULATION OF CELLULAR COMPONENT SIZE 57 337 0.0001325 0.001001
617 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 8 17 0.0001328 0.001001
618 CYTOSKELETON ORGANIZATION 120 838 0.0001336 0.001006
619 NEURAL CREST CELL MIGRATION 15 51 0.0001352 0.001013
620 NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 15 51 0.0001352 0.001013
621 CELLULAR RESPONSE TO FATTY ACID 15 51 0.0001352 0.001013
622 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 18 68 0.0001364 0.001019
623 MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 18 68 0.0001364 0.001019
624 REGULATION OF HEART RATE 21 86 0.0001386 0.001034
625 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 30 144 0.0001419 0.001056
626 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 28 131 0.0001476 0.001097
627 MESODERM DEVELOPMENT 26 118 0.0001494 0.001109
628 RESPONSE TO INTERLEUKIN 6 10 26 0.0001527 0.00113
629 REGULATION OF P38MAPK CASCADE 10 26 0.0001527 0.00113
630 REGULATION OF OSTEOCLAST DIFFERENTIATION 17 63 0.0001608 0.001186
631 NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 17 63 0.0001608 0.001186
632 AORTA DEVELOPMENT 13 41 0.000162 0.001193
633 TISSUE REMODELING 21 87 0.0001652 0.001214
634 CARDIAC ATRIUM DEVELOPMENT 11 31 0.0001671 0.001222
635 GLYCOSPHINGOLIPID METABOLIC PROCESS 18 69 0.0001669 0.001222
636 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 11 31 0.0001671 0.001222
637 POSITIVE REGULATION OF AXON EXTENSION 12 36 0.0001689 0.00123
638 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 12 36 0.0001689 0.00123
639 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 12 36 0.0001689 0.00123
640 CARDIAC VENTRICLE DEVELOPMENT 24 106 0.0001702 0.001237
641 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 15 52 0.000172 0.001249
642 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 33 166 0.0001739 0.00126
643 RESPONSE TO METAL ION 56 333 0.0001762 0.001275
644 PEPTIDYL TYROSINE DEPHOSPHORYLATION 23 100 0.0001799 0.0013
645 REGULATION OF SYNAPSE ORGANIZATION 25 113 0.0001855 0.001338
646 NEGATIVE REGULATION OF MOLECULAR FUNCTION 148 1079 0.0001858 0.001338
647 REGULATION OF COAGULATION 21 88 0.0001961 0.00141
648 REGULATION OF LIPID METABOLIC PROCESS 49 282 0.0001976 0.001419
649 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 51 297 0.0001998 0.001432
650 EXTRACELLULAR MATRIX DISASSEMBLY 19 76 0.0002041 0.001461
651 ION TRANSMEMBRANE TRANSPORT 117 822 0.0002062 0.001474
652 REGULATED EXOCYTOSIS 41 224 0.0002069 0.001477
653 DIVALENT INORGANIC CATION TRANSPORT 47 268 0.0002118 0.001509
654 DENDRITE MORPHOGENESIS 13 42 0.0002126 0.001513
655 RESPONSE TO STARVATION 31 154 0.0002133 0.001515
656 REGULATION OF EMBRYONIC DEVELOPMENT 25 114 0.0002146 0.001522
657 REGULATION OF BINDING 49 283 0.0002155 0.001526
658 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 8 18 0.0002174 0.001528
659 PLASMA MEMBRANE ORGANIZATION 38 203 0.0002171 0.001528
660 ATRIAL SEPTUM DEVELOPMENT 8 18 0.0002174 0.001528
661 SMOOTH MUSCLE TISSUE DEVELOPMENT 8 18 0.0002174 0.001528
662 KIDNEY MESENCHYME DEVELOPMENT 8 18 0.0002174 0.001528
663 REGULATION OF PROTEIN BINDING 33 168 0.0002196 0.001536
664 POSITIVE REGULATION OF HEART GROWTH 10 27 0.0002202 0.001536
665 RESPONSE TO CARBOHYDRATE 33 168 0.0002196 0.001536
666 SUBSTRATE DEPENDENT CELL MIGRATION 10 27 0.0002202 0.001536
667 HETEROTYPIC CELL CELL ADHESION 10 27 0.0002202 0.001536
668 HOMEOSTASIS OF NUMBER OF CELLS 34 175 0.000221 0.001539
669 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 7 14 0.0002225 0.00154
670 ATRIAL SEPTUM MORPHOGENESIS 7 14 0.0002225 0.00154
671 METANEPHRIC MESENCHYME DEVELOPMENT 7 14 0.0002225 0.00154
672 POSITIVE REGULATION OF FATTY ACID OXIDATION 7 14 0.0002225 0.00154
673 AXON EXTENSION 12 37 0.0002266 0.001566
674 SALIVARY GLAND DEVELOPMENT 11 32 0.0002309 0.001587
675 REGULATION OF ORGAN FORMATION 11 32 0.0002309 0.001587
676 NEGATIVE REGULATION OF PROTEIN SECRETION 24 108 0.0002303 0.001587
677 METANEPHRIC NEPHRON DEVELOPMENT 11 32 0.0002309 0.001587
678 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 16 59 0.0002334 0.001602
679 RESPONSE TO TEMPERATURE STIMULUS 30 148 0.0002357 0.001615
680 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 37 197 0.0002436 0.001667
681 RESPONSE TO CORTICOSTEROID 34 176 0.0002472 0.001673
682 REGULATION OF MYOBLAST DIFFERENTIATION 14 48 0.0002473 0.001673
683 ACTOMYOSIN STRUCTURE ORGANIZATION 19 77 0.000245 0.001673
684 MYOFIBRIL ASSEMBLY 14 48 0.0002473 0.001673
685 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 18 71 0.0002463 0.001673
686 PROTEIN DEPHOSPHORYLATION 36 190 0.0002457 0.001673
687 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 14 48 0.0002473 0.001673
688 REGULATION OF PROTEIN TARGETING 52 307 0.000246 0.001673
689 RESPONSE TO INTERLEUKIN 1 25 115 0.0002477 0.001673
690 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 28 135 0.0002516 0.001697
691 METAL ION TRANSPORT 87 582 0.00027 0.001818
692 DEPHOSPHORYLATION 49 286 0.0002782 0.001871
693 RESPONSE TO AUDITORY STIMULUS 9 23 0.0002812 0.001885
694 REGULATION OF METANEPHROS DEVELOPMENT 9 23 0.0002812 0.001885
695 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 28 136 0.0002861 0.001916
696 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 16 60 0.0002881 0.001926
697 POSITIVE REGULATION OF SECRETION 60 370 0.0002893 0.001931
698 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 17 66 0.0002959 0.001967
699 MESODERM MORPHOGENESIS 17 66 0.0002959 0.001967
700 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 17 66 0.0002959 0.001967
701 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 12 38 0.0003002 0.001982
702 CELLULAR RESPONSE TO GLUCAGON STIMULUS 12 38 0.0003002 0.001982
703 REGULATION OF ACTION POTENTIAL 12 38 0.0003002 0.001982
704 MESENCHYME MORPHOGENESIS 12 38 0.0003002 0.001982
705 POSITIVE REGULATION OF ORGAN GROWTH 12 38 0.0003002 0.001982
706 REGULATION OF CELLULAR PROTEIN LOCALIZATION 83 552 0.0003059 0.002016
707 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 24 110 0.0003083 0.002029
708 LEUKOCYTE CHEMOTAXIS 25 117 0.0003277 0.002154
709 PALATE DEVELOPMENT 20 85 0.0003366 0.002209
710 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 15 55 0.000339 0.002222
711 KIDNEY VASCULATURE DEVELOPMENT 8 19 0.0003416 0.002232
712 RENAL SYSTEM VASCULATURE DEVELOPMENT 8 19 0.0003416 0.002232
713 REGULATION OF STRIATED MUSCLE CONTRACTION 19 79 0.0003488 0.002276
714 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 6 11 0.0003538 0.002306
715 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 18 73 0.0003567 0.002307
716 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 22 98 0.0003545 0.002307
717 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 27 131 0.0003574 0.002307
718 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 24 111 0.0003554 0.002307
719 CERAMIDE METABOLIC PROCESS 18 73 0.0003567 0.002307
720 RETINA DEVELOPMENT IN CAMERA TYPE EYE 27 131 0.0003574 0.002307
721 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 18 73 0.0003567 0.002307
722 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 25 118 0.0003757 0.002418
723 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 29 145 0.0003757 0.002418
724 POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 7 15 0.0003799 0.002438
725 VENOUS BLOOD VESSEL DEVELOPMENT 7 15 0.0003799 0.002438
726 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 39 216 0.0003875 0.002483
727 POSITIVE REGULATION OF GROWTH 42 238 0.0003906 0.0025
728 NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 12 39 0.0003932 0.002507
729 ASTROCYTE DIFFERENTIATION 12 39 0.0003932 0.002507
730 NEGATIVE CHEMOTAXIS 12 39 0.0003932 0.002507
731 REGULATION OF LYMPHOCYTE DIFFERENTIATION 27 132 0.0004058 0.002583
732 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 9 24 0.0004088 0.002585
733 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 9 24 0.0004088 0.002585
734 REGULATION OF ODONTOGENESIS 9 24 0.0004088 0.002585
735 EAR MORPHOGENESIS 24 112 0.0004087 0.002585
736 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 9 24 0.0004088 0.002585
737 CELLULAR RESPONSE TO MECHANICAL STIMULUS 19 80 0.0004138 0.002612
738 REGULATION OF CELL SHAPE 28 139 0.0004161 0.002623
739 SMAD PROTEIN SIGNAL TRANSDUCTION 15 56 0.0004193 0.002629
740 EPITHELIAL TO MESENCHYMAL TRANSITION 15 56 0.0004193 0.002629
741 REGULATION OF DENDRITIC SPINE DEVELOPMENT 15 56 0.0004193 0.002629
742 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 15 56 0.0004193 0.002629
743 ADHERENS JUNCTION ASSEMBLY 11 34 0.0004215 0.00264
744 RESPONSE TO ESTRADIOL 29 146 0.0004233 0.002648
745 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 10 29 0.0004309 0.002688
746 RESPONSE TO ISCHEMIA 10 29 0.0004309 0.002688
747 REGULATION OF ALPHA BETA T CELL ACTIVATION 17 68 0.000433 0.002697
748 CATION TRANSPORT 112 796 0.0004337 0.002698
749 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 21 93 0.0004397 0.002731
750 GLYCOPROTEIN METABOLIC PROCESS 57 353 0.000451 0.002798
751 ENDOTHELIAL CELL DEVELOPMENT 13 45 0.0004527 0.002801
752 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 13 45 0.0004527 0.002801
753 MYELOID CELL DIFFERENTIATION 35 189 0.0004643 0.002869
754 RESPONSE TO ESTROGEN 39 218 0.0004683 0.002886
755 PROTEIN LOCALIZATION 229 1805 0.0004678 0.002886
756 POSITIVE REGULATION OF PROTEIN SECRETION 38 211 0.0004809 0.00296
757 CYTOKINE PRODUCTION 25 120 0.0004903 0.00301
758 REGULATION OF DENDRITE DEVELOPMENT 25 120 0.0004903 0.00301
759 MULTI ORGANISM BEHAVIOR 18 75 0.0005077 0.003112
760 LYMPH VESSEL DEVELOPMENT 8 20 0.0005179 0.003171
761 INTERACTION WITH HOST 27 134 0.0005203 0.003181
762 REGULATION OF APOPTOTIC SIGNALING PATHWAY 58 363 0.0005297 0.003234
763 APPENDAGE DEVELOPMENT 32 169 0.000534 0.003252
764 LIMB DEVELOPMENT 32 169 0.000534 0.003252
765 DIGESTIVE SYSTEM DEVELOPMENT 29 148 0.0005349 0.003253
766 SENSORY PERCEPTION OF MECHANICAL STIMULUS 30 155 0.0005373 0.003259
767 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 30 155 0.0005373 0.003259
768 OVULATION CYCLE PROCESS 20 88 0.0005451 0.003302
769 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 11 35 0.0005578 0.003375
770 PHOSPHOLIPID METABOLIC PROCESS 58 364 0.000568 0.003432
771 REGULATION OF PHOSPHATASE ACTIVITY 26 128 0.0005752 0.00347
772 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 19 82 0.0005756 0.00347
773 RESPONSE TO BIOTIC STIMULUS 122 886 0.0005769 0.003472
774 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 9 25 0.0005806 0.00349
775 NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 10 30 0.0005869 0.003506
776 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 10 30 0.0005869 0.003506
777 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 10 30 0.0005869 0.003506
778 REGULATION OF MEMBRANE REPOLARIZATION 10 30 0.0005869 0.003506
779 LAMELLIPODIUM ASSEMBLY 10 30 0.0005869 0.003506
780 CANONICAL WNT SIGNALING PATHWAY 21 95 0.0005942 0.003544
781 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 14 52 0.0006109 0.00364
782 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 7 16 0.0006153 0.003661
783 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 17 70 0.0006215 0.003693
784 NEGATIVE REGULATION OF WOUND HEALING 15 58 0.0006296 0.003736
785 CELLULAR RESPONSE TO EPINEPHRINE STIMULUS 6 12 0.0006458 0.003818
786 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 12 0.0006458 0.003818
787 MECHANOSENSORY BEHAVIOR 6 12 0.0006458 0.003818
788 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 12 41 0.0006532 0.003853
789 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 48 289 0.0006533 0.003853
790 DEVELOPMENTAL CELL GROWTH 18 77 0.0007108 0.004186
791 POSITIVE REGULATION OF GLIOGENESIS 13 47 0.0007168 0.004217
792 REGULATION OF IMMUNE RESPONSE 118 858 0.0007383 0.004338
793 REGULATION OF GLIOGENESIS 20 90 0.0007393 0.004338
794 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 14 53 0.0007523 0.004408
795 CHONDROCYTE DEVELOPMENT 8 21 0.0007612 0.004422
796 DECIDUALIZATION 8 21 0.0007612 0.004422
797 CELL AGGREGATION 8 21 0.0007612 0.004422
798 REGULATION OF CHEMOKINE PRODUCTION 16 65 0.0007589 0.004422
799 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 8 21 0.0007612 0.004422
800 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 8 21 0.0007612 0.004422
801 CARTILAGE CONDENSATION 8 21 0.0007612 0.004422
802 MATERNAL PLACENTA DEVELOPMENT 10 31 0.0007869 0.004565
803 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 97 684 0.0007884 0.004569
804 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 19 84 0.0007895 0.004569
805 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 9 26 0.0008071 0.004659
806 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 9 26 0.0008071 0.004659
807 CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 140 1047 0.0008099 0.00467
808 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 12 42 0.0008294 0.004777
809 REGULATION OF INTERLEUKIN 6 PRODUCTION 22 104 0.0008383 0.004822
810 NEGATIVE REGULATION OF CELL CYCLE 66 433 0.0008422 0.004838
811 POSITIVE REGULATION OF WOUND HEALING 13 48 0.0008912 0.005113
812 ACTIN FILAMENT ORGANIZATION 32 174 0.0008966 0.005138
813 MYELOID LEUKOCYTE ACTIVATION 21 98 0.0009134 0.005228
814 POSITIVE REGULATION OF CALCIUM ION IMPORT 14 54 0.0009202 0.00526
815 REGULATION OF DOPAMINE METABOLIC PROCESS 7 17 0.0009531 0.005317
816 REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 7 17 0.0009531 0.005317
817 CORONARY VASCULATURE DEVELOPMENT 11 37 0.0009415 0.005317
818 NEGATIVE REGULATION OF PLATELET ACTIVATION 7 17 0.0009531 0.005317
819 REGULATION OF NOREPINEPHRINE SECRETION 7 17 0.0009531 0.005317
820 REGULATION OF RECEPTOR BINDING 7 17 0.0009531 0.005317
821 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 7 17 0.0009531 0.005317
822 REGULATION OF PLATELET AGGREGATION 7 17 0.0009531 0.005317
823 REGULATION OF PROTEIN KINASE A SIGNALING 7 17 0.0009531 0.005317
824 REGULATION OF MUSCLE HYPERTROPHY 11 37 0.0009415 0.005317
825 REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE 7 17 0.0009531 0.005317
826 NEGATIVE REGULATION OF ANOIKIS 7 17 0.0009531 0.005317
827 MAMMARY GLAND ALVEOLUS DEVELOPMENT 7 17 0.0009531 0.005317
828 MAMMARY GLAND LOBULE DEVELOPMENT 7 17 0.0009531 0.005317
829 MATURE B CELL DIFFERENTIATION 7 17 0.0009531 0.005317
830 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 7 17 0.0009531 0.005317
831 IMPORT INTO CELL 11 37 0.0009415 0.005317
832 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 7 17 0.0009531 0.005317
833 REGULATION OF CATECHOLAMINE METABOLIC PROCESS 7 17 0.0009531 0.005317
834 ACTIVATION OF PROTEIN KINASE A ACTIVITY 7 17 0.0009531 0.005317
835 REGULATION OF SYNAPSE ASSEMBLY 18 79 0.0009799 0.00546
836 INNER EAR MORPHOGENESIS 20 92 0.0009905 0.005513
837 REGENERATION 30 161 0.001026 0.005705
838 CELLULAR RESPONSE TO KETONE 17 73 0.001034 0.005743
839 CELL CYCLE ARREST 29 154 0.001039 0.005745
840 POSITIVE REGULATION OF VASODILATION 10 32 0.00104 0.005745
841 BLOOD VESSEL REMODELING 10 32 0.00104 0.005745
842 NEGATIVE REGULATION OF T CELL DIFFERENTIATION 10 32 0.00104 0.005745
843 CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 12 43 0.001044 0.00576
844 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 59 381 0.001049 0.005785
845 CELLULAR RESPONSE TO DRUG 16 67 0.001079 0.005942
846 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 8 22 0.001089 0.005959
847 ACTIVIN RECEPTOR SIGNALING PATHWAY 8 22 0.001089 0.005959
848 REGULATION OF INTERLEUKIN 17 PRODUCTION 8 22 0.001089 0.005959
849 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 8 22 0.001089 0.005959
850 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 8 22 0.001089 0.005959
851 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 9 27 0.001101 0.005974
852 HIPPO SIGNALING 9 27 0.001101 0.005974
853 BEHAVIORAL RESPONSE TO PAIN 6 13 0.001095 0.005974
854 CARDIOBLAST DIFFERENTIATION 6 13 0.001095 0.005974
855 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 13 49 0.0011 0.005974
856 REGULATION OF CATENIN IMPORT INTO NUCLEUS 9 27 0.001101 0.005974
857 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 9 27 0.001101 0.005974
858 TRANSMEMBRANE TRANSPORT 145 1098 0.001102 0.005974
859 CRANIAL SKELETAL SYSTEM DEVELOPMENT 14 55 0.001119 0.00606
860 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 23 113 0.001128 0.006105
861 REGULATION OF VESICLE MEDIATED TRANSPORT 69 462 0.001133 0.00612
862 RESPONSE TO NUTRIENT 34 191 0.001141 0.00616
863 REGULATION OF DEFENSE RESPONSE 105 759 0.001159 0.00625
864 NEGATIVE REGULATION OF ION TRANSPORT 25 127 0.001167 0.006285
865 CELLULAR RESPONSE TO OXIDATIVE STRESS 33 184 0.001174 0.006315
866 RESPONSE TO BACTERIUM 77 528 0.001209 0.006495
867 NEGATIVE REGULATION OF HORMONE SECRETION 17 74 0.001215 0.006523
868 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 19 87 0.001237 0.006583
869 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 19 87 0.001237 0.006583
870 VIRAL ENTRY INTO HOST CELL 19 87 0.001237 0.006583
871 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 19 87 0.001237 0.006583
872 MOVEMENT IN HOST ENVIRONMENT 19 87 0.001237 0.006583
873 ENTRY INTO HOST 19 87 0.001237 0.006583
874 ENTRY INTO HOST CELL 19 87 0.001237 0.006583
875 POSITIVE REGULATION OF HEMOPOIESIS 30 163 0.001259 0.006694
876 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 16 68 0.001278 0.006787
877 POSITIVE REGULATION OF MAP KINASE ACTIVITY 36 207 0.00128 0.006792
878 SYNAPTIC SIGNALING 64 424 0.001284 0.006803
879 REGULATION OF PROTEIN KINASE B SIGNALING 24 121 0.001299 0.006878
880 NEGATIVE REGULATION OF HEMOPOIESIS 25 128 0.001311 0.00693
881 CARDIAC VENTRICLE MORPHOGENESIS 15 62 0.001326 0.007001
882 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 18 81 0.001331 0.007008
883 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 18 81 0.001331 0.007008
884 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 18 81 0.001331 0.007008
885 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 13 50 0.001347 0.007069
886 STAT CASCADE 13 50 0.001347 0.007069
887 JAK STAT CASCADE 13 50 0.001347 0.007069
888 NEURON RECOGNITION 10 33 0.001355 0.007083
889 POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 10 33 0.001355 0.007083
890 OUTFLOW TRACT MORPHOGENESIS 14 56 0.001352 0.007083
891 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 21 101 0.00137 0.007156
892 CALCIUM ION TRANSPORT 38 223 0.001406 0.007335
893 REGULATION OF EXOCYTOSIS 33 186 0.001416 0.007379
894 REGULATION OF HETEROTYPIC CELL CELL ADHESION 7 18 0.001421 0.007389
895 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 7 18 0.001421 0.007389
896 CELLULAR RESPONSE TO INTERLEUKIN 1 19 88 0.001427 0.007411
897 RESPONSE TO ETHANOL 26 136 0.001467 0.007605
898 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 25 129 0.001469 0.007605
899 REGULATION OF CAMP METABOLIC PROCESS 25 129 0.001469 0.007605
900 RIBONUCLEOTIDE CATABOLIC PROCESS 9 28 0.001475 0.007607
901 MUSCLE HYPERTROPHY 9 28 0.001475 0.007607
902 REGULATION OF FATTY ACID OXIDATION 9 28 0.001475 0.007607
903 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 31 172 0.001499 0.007715
904 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 31 172 0.001499 0.007715
905 ANTERIOR POSTERIOR PATTERN SPECIFICATION 34 194 0.001502 0.007721
906 REGULATION OF PHOSPHOLIPASE C ACTIVITY 11 39 0.001521 0.007742
907 REGULATION OF AXON GUIDANCE 11 39 0.001521 0.007742
908 POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 11 39 0.001521 0.007742
909 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 8 23 0.001519 0.007742
910 TRABECULA MORPHOGENESIS 11 39 0.001521 0.007742
911 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 11 39 0.001521 0.007742
912 TRABECULA FORMATION 8 23 0.001519 0.007742
913 REGULATION OF RESPIRATORY GASEOUS EXCHANGE 8 23 0.001519 0.007742
914 NEUROTROPHIN SIGNALING PATHWAY 8 23 0.001519 0.007742
915 REGULATION OF DEPHOSPHORYLATION 29 158 0.001569 0.007981
916 GLYCEROLIPID METABOLIC PROCESS 55 356 0.001603 0.008144
917 EXOCRINE SYSTEM DEVELOPMENT 12 45 0.001611 0.008154
918 SMOOTH MUSCLE CONTRACTION 12 45 0.001611 0.008154
919 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 12 45 0.001611 0.008154
920 REGULATION OF JAK STAT CASCADE 27 144 0.001621 0.008189
921 REGULATION OF STAT CASCADE 27 144 0.001621 0.008189
922 FEMALE SEX DIFFERENTIATION 23 116 0.001628 0.008218
923 NEGATIVE REGULATION OF CHEMOTAXIS 13 51 0.00164 0.008249
924 NEGATIVE REGULATION OF CALCIUM ION TRANSPORT 13 51 0.00164 0.008249
925 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 13 51 0.00164 0.008249
926 CELLULAR RESPONSE TO ABIOTIC STIMULUS 43 263 0.001659 0.008338
927 POSITIVE REGULATION OF CYTOKINE SECRETION 20 96 0.001717 0.008621
928 REGULATION OF CYTOSKELETON ORGANIZATION 73 502 0.001722 0.008632
929 SULFUR COMPOUND BIOSYNTHETIC PROCESS 35 203 0.001727 0.00865
930 RESPONSE TO RADIATION 62 413 0.001729 0.008653
931 POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 6 14 0.001749 0.008656
932 POSITIVE REGULATION OF VACUOLAR TRANSPORT 6 14 0.001749 0.008656
933 POSITIVE REGULATION OF SODIUM ION TRANSPORT 10 34 0.001744 0.008656
934 EPITHELIAL CELL CELL ADHESION 6 14 0.001749 0.008656
935 RESPONSE TO PROSTAGLANDIN 10 34 0.001744 0.008656
936 POSITIVE REGULATION OF P38MAPK CASCADE 6 14 0.001749 0.008656
937 REGULATION OF GLOMERULUS DEVELOPMENT 6 14 0.001749 0.008656
938 CAMP CATABOLIC PROCESS 6 14 0.001749 0.008656
939 CELLULAR RESPONSE TO VITAMIN D 6 14 0.001749 0.008656
940 POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY 6 14 0.001749 0.008656
941 PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 18 83 0.001785 0.008806
942 RESPONSE TO FATTY ACID 18 83 0.001785 0.008806
943 REGULATION OF POTASSIUM ION TRANSPORT 18 83 0.001785 0.008806
944 LIPID LOCALIZATION 43 264 0.001788 0.008815
945 SPHINGOLIPID METABOLIC PROCESS 26 138 0.001822 0.008973
946 CELLULAR RESPONSE TO STARVATION 23 117 0.001833 0.009014
947 REGIONALIZATION 49 311 0.001851 0.009095
948 REGULATION OF PHOSPHOLIPASE ACTIVITY 15 64 0.001865 0.009156
949 CALCIUM MEDIATED SIGNALING 19 90 0.001883 0.009234
950 TYROSINE PHOSPHORYLATION OF STAT PROTEIN 5 10 0.001897 0.00929
951 POSITIVE REGULATION OF CELL MATRIX ADHESION 11 40 0.001904 0.009308
952 NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 11 40 0.001904 0.009308
953 REGULATION OF SODIUM ION TRANSPORT 17 77 0.001928 0.009405
954 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 17 77 0.001928 0.009405
955 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 9 29 0.001944 0.009443
956 REGULATION OF VACUOLAR TRANSPORT 9 29 0.001944 0.009443
957 RESPONSE TO PAIN 9 29 0.001944 0.009443
958 MUSCLE ADAPTATION 9 29 0.001944 0.009443
959 REGULATION OF INTERLEUKIN 10 PRODUCTION 12 46 0.001977 0.009543
960 PEPTIDYL THREONINE MODIFICATION 12 46 0.001977 0.009543
961 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 12 46 0.001977 0.009543
962 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 12 46 0.001977 0.009543
963 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 12 46 0.001977 0.009543
964 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 12 46 0.001977 0.009543
965 REGULATION OF LIPID CATABOLIC PROCESS 13 52 0.001983 0.009561
966 CELLULAR RESPONSE TO INSULIN STIMULUS 27 146 0.001995 0.00961
967 REGULATION OF NEUROTRANSMITTER LEVELS 33 190 0.002033 0.009781
968 APOPTOTIC SIGNALING PATHWAY 46 289 0.002038 0.009799
969 FIBRIL ORGANIZATION 7 19 0.002051 0.009828
970 NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS 7 19 0.002051 0.009828
971 NEGATIVE REGULATION OF ATP METABOLIC PROCESS 7 19 0.002051 0.009828
972 POSITIVE REGULATION OF IMMUNE RESPONSE 80 563 0.002057 0.009845
973 STEROID HORMONE MEDIATED SIGNALING PATHWAY 24 125 0.002059 0.009848
974 ADHERENS JUNCTION ORGANIZATION 16 71 0.002068 0.00988
975 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 8 24 0.002074 0.009889
976 REGULATION OF ANOIKIS 8 24 0.002074 0.009889
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 253 1476 7.126e-17 6.62e-14
2 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 131 629 2.363e-15 1.097e-12
3 ENZYME BINDING 279 1737 8.088e-15 2.505e-12
4 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 81 328 5.235e-14 1.216e-11
5 CALCIUM ION BINDING 135 697 3.039e-13 5.646e-11
6 KINASE BINDING 119 606 3.165e-12 4.9e-10
7 GROWTH FACTOR BINDING 41 123 4.059e-12 5.387e-10
8 CYTOSKELETAL PROTEIN BINDING 148 819 5.9e-12 6.851e-10
9 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 74 315 8.875e-12 9.161e-10
10 ACTIN BINDING 86 393 1.095e-11 1.017e-09
11 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 58 226 3.883e-11 3.279e-09
12 REGULATORY REGION NUCLEIC ACID BINDING 144 818 8.13e-11 6.294e-09
13 CYTOKINE BINDING 32 92 2.618e-10 1.737e-08
14 PROTEIN KINASE ACTIVITY 118 640 2.524e-10 1.737e-08
15 MACROMOLECULAR COMPLEX BINDING 217 1399 3.114e-10 1.929e-08
16 CELL ADHESION MOLECULE BINDING 49 186 4.754e-10 2.76e-08
17 PROTEIN COMPLEX BINDING 156 935 7.617e-10 4.042e-08
18 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 190 1199 7.831e-10 4.042e-08
19 PROTEIN DOMAIN SPECIFIC BINDING 114 624 8.948e-10 4.375e-08
20 KINASE ACTIVITY 143 842 1.202e-09 5.583e-08
21 CORECEPTOR ACTIVITY 18 38 7.462e-09 3.301e-07
22 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 64 303 2.006e-08 8.472e-07
23 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 52 228 3.08e-08 1.192e-06
24 MOLECULAR FUNCTION REGULATOR 202 1353 3.034e-08 1.192e-06
25 CYTOKINE RECEPTOR BINDING 58 271 5.633e-08 2.093e-06
26 HEPARIN BINDING 39 157 1.51e-07 5.373e-06
27 INTEGRIN BINDING 30 105 1.562e-07 5.373e-06
28 ION CHANNEL BINDING 31 111 1.72e-07 5.708e-06
29 DOUBLE STRANDED DNA BINDING 124 764 2.135e-07 6.839e-06
30 RECEPTOR SIGNALING PROTEIN ACTIVITY 41 172 2.452e-07 7.594e-06
31 COLLAGEN BINDING 22 65 2.772e-07 8.307e-06
32 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 25 81 3.307e-07 9.036e-06
33 EXTRACELLULAR MATRIX BINDING 19 51 3.239e-07 9.036e-06
34 GLYCOSAMINOGLYCAN BINDING 46 205 3.117e-07 9.036e-06
35 PHOSPHORIC ESTER HYDROLASE ACTIVITY 70 368 3.407e-07 9.043e-06
36 CORE PROMOTER PROXIMAL REGION DNA BINDING 70 371 4.673e-07 1.206e-05
37 IDENTICAL PROTEIN BINDING 178 1209 5.475e-07 1.375e-05
38 TRANSCRIPTION FACTOR BINDING 90 524 9.105e-07 2.174e-05
39 CYTOKINE ACTIVITY 47 219 9.128e-07 2.174e-05
40 SULFUR COMPOUND BINDING 49 234 1.154e-06 2.665e-05
41 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 22 70 1.176e-06 2.665e-05
42 PROTEIN HOMODIMERIZATION ACTIVITY 115 722 1.529e-06 3.383e-05
43 SIGNAL TRANSDUCER ACTIVITY 238 1731 1.608e-06 3.473e-05
44 PROTEIN DIMERIZATION ACTIVITY 168 1149 1.782e-06 3.763e-05
45 SIALYLTRANSFERASE ACTIVITY 11 21 1.853e-06 3.826e-05
46 SMAD BINDING 22 72 2.001e-06 4.041e-05
47 ACTIVATING TRANSCRIPTION FACTOR BINDING 19 57 2.316e-06 4.577e-05
48 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 148 992 2.452e-06 4.746e-05
49 GLYCOPROTEIN BINDING 27 101 2.661e-06 5.045e-05
50 METALLOENDOPEPTIDASE ACTIVITY 29 113 2.831e-06 5.26e-05
51 CATION CHANNEL ACTIVITY 57 298 3.409e-06 6.209e-05
52 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 22 76 5.4e-06 9.647e-05
53 GROWTH FACTOR RECEPTOR BINDING 31 129 5.763e-06 0.000101
54 LIPID BINDING 104 657 6.366e-06 0.0001095
55 TRANSFORMING GROWTH FACTOR BETA BINDING 9 16 7.719e-06 0.0001304
56 VOLTAGE GATED ION CHANNEL ACTIVITY 40 190 9.357e-06 0.0001552
57 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 24 90 9.828e-06 0.0001602
58 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 94 588 1.177e-05 0.0001853
59 SEQUENCE SPECIFIC DNA BINDING 150 1037 1.165e-05 0.0001853
60 PROTEIN SERINE THREONINE KINASE ACTIVITY 75 445 1.431e-05 0.0002216
61 SH3 DOMAIN BINDING 28 116 1.465e-05 0.0002232
62 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 36 168 1.708e-05 0.0002518
63 E BOX BINDING 13 34 1.705e-05 0.0002518
64 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 77 464 1.935e-05 0.0002809
65 WNT PROTEIN BINDING 12 31 3.112e-05 0.0004448
66 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 8 15 4.252e-05 0.0005984
67 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 15 48 6.249e-05 0.0008664
68 STEROID HORMONE RECEPTOR ACTIVITY 17 59 6.579e-05 0.0008989
69 CALMODULIN BINDING 36 179 7.044e-05 0.0009483
70 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 9 20 7.707e-05 0.001023
71 ZINC ION BINDING 159 1155 8.976e-05 0.001174
72 BETA CATENIN BINDING 21 84 9.657e-05 0.001246
73 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 68 417 9.988e-05 0.001271
74 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 8 17 0.0001328 0.001667
75 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 22 92 0.0001351 0.001674
76 GATED CHANNEL ACTIVITY 55 325 0.0001697 0.002074
77 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 17 64 0.0001982 0.002391
78 ACTIN FILAMENT BINDING 26 121 0.000229 0.002727
79 PROTEIN TYROSINE KINASE ACTIVITY 34 176 0.0002472 0.002907
80 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 21 90 0.0002735 0.003176
81 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 23 103 0.0002858 0.003277
82 FIBRONECTIN BINDING 10 28 0.0003109 0.003523
83 PROTEASE BINDING 23 104 0.0003315 0.003711
84 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 23 105 0.0003837 0.004243
85 METALLOPEPTIDASE ACTIVITY 35 188 0.0004192 0.004581
86 GROWTH FACTOR ACTIVITY 31 160 0.0004301 0.004592
87 PHOSPHOLIPID BINDING 58 360 0.0004282 0.004592
88 ENZYME ACTIVATOR ACTIVITY 72 471 0.0004626 0.004884
89 UBIQUITIN LIKE PROTEIN LIGASE BINDING 45 264 0.0005401 0.005638
90 BETA AMYLOID BINDING 11 35 0.0005578 0.005758
91 LAMININ BINDING 10 30 0.0005869 0.005992
92 TUBULIN BINDING 46 273 0.0006101 0.006161
93 CYTOKINE RECEPTOR ACTIVITY 20 89 0.0006358 0.006351
94 RECEPTOR ACTIVITY 210 1649 0.0006653 0.006575
95 PDZ DOMAIN BINDING 20 90 0.0007393 0.00723
96 CHEMOKINE BINDING 8 21 0.0007612 0.007366
97 PROTEIN KINASE A BINDING 12 42 0.0008294 0.007944
98 PROTEIN BINDING INVOLVED IN CELL ADHESION 7 17 0.0009531 0.009035
99 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 26 133 0.001047 0.009823
NumGOOverlapSizeP ValueAdj. P Value
1 INTRINSIC COMPONENT OF PLASMA MEMBRANE 295 1649 1.594e-22 9.309e-20
2 CELL JUNCTION 224 1151 1.072e-21 3.132e-19
3 MEMBRANE REGION 221 1134 1.732e-21 3.371e-19
4 CELL SURFACE 156 757 1.214e-17 1.773e-15
5 MEMBRANE MICRODOMAIN 79 288 2.045e-16 2.389e-14
6 PROTEINACEOUS EXTRACELLULAR MATRIX 89 356 1.324e-15 1.289e-13
7 SYNAPSE 149 754 2.939e-15 1.716e-13
8 NEURON PROJECTION 176 942 2.111e-15 1.716e-13
9 PLASMA MEMBRANE REGION 174 929 2.433e-15 1.716e-13
10 CELL PROJECTION 287 1786 2.91e-15 1.716e-13
11 NEURON PART 219 1265 3.808e-15 2.022e-13
12 EXTRACELLULAR MATRIX 99 426 5.527e-15 2.69e-13
13 CELL SUBSTRATE JUNCTION 93 398 2.631e-14 1.182e-12
14 PLASMA MEMBRANE PROTEIN COMPLEX 108 510 2.343e-13 9.775e-12
15 CELL LEADING EDGE 83 350 2.791e-13 1.087e-11
16 SOMATODENDRITIC COMPARTMENT 127 650 8.334e-13 3.042e-11
17 RECEPTOR COMPLEX 78 327 1.06e-12 3.641e-11
18 ANCHORING JUNCTION 103 489 1.202e-12 3.898e-11
19 POSTSYNAPSE 82 378 5.254e-11 1.534e-09
20 SYNAPSE PART 116 610 5.016e-11 1.534e-09
21 EXTRACELLULAR MATRIX COMPONENT 39 125 1.301e-10 3.618e-09
22 SIDE OF MEMBRANE 88 428 1.992e-10 5.288e-09
23 DENDRITE 91 451 2.748e-10 6.978e-09
24 GOLGI APPARATUS 220 1445 1.249e-09 3.04e-08
25 ACTIN CYTOSKELETON 87 444 3.041e-09 7.103e-08
26 CELL CELL JUNCTION 78 383 3.348e-09 7.521e-08
27 EXCITATORY SYNAPSE 48 197 1.135e-08 2.454e-07
28 CELL BODY 92 494 1.479e-08 3.084e-07
29 PLASMA MEMBRANE RAFT 28 86 1.806e-08 3.636e-07
30 LAMELLIPODIUM 43 172 2.904e-08 5.653e-07
31 CELL CELL CONTACT ZONE 23 64 4.173e-08 7.615e-07
32 CONTRACTILE FIBER 49 211 4.171e-08 7.615e-07
33 EXTERNAL SIDE OF PLASMA MEMBRANE 53 238 5.301e-08 9.382e-07
34 INTERCALATED DISC 20 51 5.833e-08 1.002e-06
35 SYNAPTIC MEMBRANE 56 261 8.676e-08 1.448e-06
36 FILOPODIUM 28 94 1.535e-07 2.49e-06
37 ENDOPLASMIC RETICULUM 232 1631 1.593e-07 2.515e-06
38 CELL PROJECTION PART 147 946 2.447e-07 3.76e-06
39 CATION CHANNEL COMPLEX 40 167 2.987e-07 4.473e-06
40 RUFFLE 38 156 3.712e-07 5.419e-06
41 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 14 30 4.473e-07 6.371e-06
42 EXTRACELLULAR SPACE 197 1376 9.593e-07 1.303e-05
43 SARCOLEMMA 32 125 9.392e-07 1.303e-05
44 I BAND 31 121 1.356e-06 1.8e-05
45 AXON 75 418 1.389e-06 1.802e-05
46 BASEMENT MEMBRANE 26 93 1.621e-06 2.058e-05
47 NEURON SPINE 30 121 4.126e-06 5.127e-05
48 LEADING EDGE MEMBRANE 32 134 4.729e-06 5.636e-05
49 ACTIN FILAMENT 21 70 4.708e-06 5.636e-05
50 GOLGI APPARATUS PART 134 893 5.496e-06 6.397e-05
51 T TUBULE 16 45 5.586e-06 6.397e-05
52 VACUOLE 169 1180 5.804e-06 6.518e-05
53 ACTOMYOSIN 19 62 9.381e-06 0.0001034
54 INTRACELLULAR VESICLE 176 1259 1.57e-05 0.0001698
55 CORTICAL CYTOSKELETON 22 81 1.661e-05 0.0001733
56 ACTIN BASED CELL PROJECTION 38 181 1.652e-05 0.0001733
57 MEMBRANE PROTEIN COMPLEX 147 1020 1.728e-05 0.0001771
58 SITE OF POLARIZED GROWTH 33 149 1.85e-05 0.0001832
59 ENDOSOME 119 793 1.836e-05 0.0001832
60 CYTOPLASMIC REGION 53 287 2.072e-05 0.0002017
61 VOLTAGE GATED SODIUM CHANNEL COMPLEX 8 14 2.182e-05 0.0002089
62 CELL CORTEX PART 28 119 2.429e-05 0.0002288
63 POSTSYNAPTIC MEMBRANE 41 205 2.635e-05 0.0002443
64 PERINUCLEAR REGION OF CYTOPLASM 99 642 3.121e-05 0.0002848
65 BASAL PART OF CELL 16 51 3.395e-05 0.0003051
66 CYTOSKELETON 256 1967 3.926e-05 0.0003474
67 PLASMA MEMBRANE RECEPTOR COMPLEX 36 175 4.295e-05 0.0003744
68 COMPLEX OF COLLAGEN TRIMERS 10 23 4.399e-05 0.0003778
69 RUFFLE MEMBRANE 21 80 4.47e-05 0.0003783
70 CELL CORTEX 45 238 4.691e-05 0.0003914
71 CORTICAL ACTIN CYTOSKELETON 17 58 5.178e-05 0.0004259
72 COLLAGEN TRIMER 22 88 6.651e-05 0.0005395
73 FILAMENTOUS ACTIN 9 20 7.707e-05 0.0006166
74 ENDOPLASMIC RETICULUM LUMEN 39 201 8.191e-05 0.0006464
75 AXON PART 41 219 0.0001249 0.0009724
76 SODIUM CHANNEL COMPLEX 8 17 0.0001328 0.00102
77 GOLGI MEMBRANE 103 703 0.0001675 0.00127
78 PRESYNAPSE 49 283 0.0002155 0.001614
79 APICAL PART OF CELL 59 361 0.0002626 0.001941
80 CYTOPLASMIC VESICLE PART 89 601 0.0003174 0.002317
81 TRANSPORTER COMPLEX 53 321 0.0004091 0.002949
82 BASOLATERAL PLASMA MEMBRANE 38 211 0.0004809 0.003425
83 ENDOPLASMIC RETICULUM PART 155 1163 0.0005011 0.003526
84 NEURON PROJECTION TERMINUS 26 129 0.0006508 0.004525
85 POTASSIUM CHANNEL COMPLEX 20 90 0.0007393 0.00508
86 DENDRITIC SHAFT 11 37 0.0009415 0.006394
87 COATED PIT 16 67 0.001079 0.007243
88 PRESYNAPTIC MEMBRANE 14 55 0.001119 0.007424
89 VESICLE MEMBRANE 75 512 0.001228 0.008056
90 CELL PROJECTION MEMBRANE 48 298 0.001284 0.008329
91 PLATELET ALPHA GRANULE 17 75 0.001423 0.009033
92 PERIKARYON 22 108 0.001414 0.009033
93 APICAL PLASMA MEMBRANE 47 292 0.001454 0.00913

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Focal_adhesion_hsa04510 58 199 1.201e-13 6.243e-12
2 PI3K_Akt_signaling_pathway_hsa04151 81 352 2.907e-12 7.557e-11
3 MAPK_signaling_pathway_hsa04010 69 295 5.501e-11 9.535e-10
4 Cytokine_cytokine_receptor_interaction_hsa04060 63 270 4.163e-10 5.411e-09
5 ECM_receptor_interaction_hsa04512 29 82 1.143e-09 1.188e-08
6 Cell_adhesion_molecules_.CAMs._hsa04514 39 145 1.471e-08 1.275e-07
7 Apelin_signaling_pathway_hsa04371 35 137 3.122e-07 2.319e-06
8 Regulation_of_actin_cytoskeleton_hsa04810 45 208 1.224e-06 7.813e-06
9 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 34 139 1.352e-06 7.813e-06
10 cGMP_PKG_signaling_pathway_hsa04022 37 163 3.234e-06 1.682e-05
11 Wnt_signaling_pathway_hsa04310 33 146 1.182e-05 5.589e-05
12 Calcium_signaling_pathway_hsa04020 38 182 1.884e-05 8.105e-05
13 Gap_junction_hsa04540 23 88 2.131e-05 8.105e-05
14 HIF_1_signaling_pathway_hsa04066 25 100 2.182e-05 8.105e-05
15 TGF_beta_signaling_pathway_hsa04350 22 84 3.086e-05 0.000107
16 Hippo_signaling_pathway_hsa04390 33 154 3.761e-05 0.0001222
17 Jak_STAT_signaling_pathway_hsa04630 34 162 4.526e-05 0.0001385
18 Rap1_signaling_pathway_hsa04015 39 206 0.0001413 0.0004082
19 TNF_signaling_pathway_hsa04668 24 108 0.0002303 0.0006302
20 cAMP_signaling_pathway_hsa04024 37 198 0.0002703 0.0007028
21 Ras_signaling_pathway_hsa04014 41 232 0.0004414 0.001093
22 NF_kappa_B_signaling_pathway_hsa04064 21 95 0.0005942 0.001404
23 Adherens_junction_hsa04520 17 72 0.0008764 0.001807
24 Sphingolipid_signaling_pathway_hsa04071 24 118 0.0009009 0.001807
25 ErbB_signaling_pathway_hsa04012 19 85 0.0009199 0.001807
26 Cellular_senescence_hsa04218 30 160 0.0009246 0.001807
27 Phospholipase_D_signaling_pathway_hsa04072 28 146 0.0009381 0.001807
28 FoxO_signaling_pathway_hsa04068 25 132 0.002048 0.003803
29 Hippo_signaling_pathway_multiple_species_hsa04392 8 29 0.007584 0.0136
30 Phosphatidylinositol_signaling_system_hsa04070 17 99 0.02483 0.04304
31 Apoptosis_hsa04210 22 138 0.02634 0.04418
32 Tight_junction_hsa04530 26 170 0.02723 0.04425
33 ABC_transporters_hsa02010 9 45 0.03835 0.06043
34 AMPK_signaling_pathway_hsa04152 19 121 0.04232 0.06472
35 Neuroactive_ligand_receptor_interaction_hsa04080 37 278 0.06573 0.09766
36 Autophagy_animal_hsa04140 19 128 0.06784 0.098
37 Oocyte_meiosis_hsa04114 18 124 0.08752 0.123
38 Phagosome_hsa04145 21 152 0.1036 0.1417
39 Ferroptosis_hsa04216 7 40 0.1136 0.1514
40 mTOR_signaling_pathway_hsa04150 20 151 0.1488 0.1924
41 VEGF_signaling_pathway_hsa04370 9 59 0.1517 0.1924
42 p53_signaling_pathway_hsa04115 10 68 0.161 0.1994
43 Lysosome_hsa04142 16 123 0.2006 0.2426
44 Hedgehog_signaling_pathway_hsa04340 7 47 0.2082 0.2461
45 Notch_signaling_pathway_hsa04330 7 48 0.2237 0.2585
46 Apoptosis_multiple_species_hsa04215 5 33 0.2516 0.2844
47 Necroptosis_hsa04217 19 164 0.3353 0.371
48 Mitophagy_animal_hsa04137 8 65 0.3572 0.387
49 Endocytosis_hsa04144 26 244 0.4663 0.4949
50 Cell_cycle_hsa04110 13 124 0.5224 0.5433
51 Autophagy_other_hsa04136 2 32 0.8575 0.8743
52 Peroxisome_hsa04146 5 83 0.9397 0.9397

Quest ID: 91716777bfbd5fe6f0191590785ed107